References

National Clinical Guideline Centre (UK)

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Clinical Guideline Centre (UK). Headaches: Diagnosis and Management of Headaches in Young People and Adults [Internet]. London: Royal College of Physicians (UK); 2012 Sep. (NICE Clinical Guidelines, No. 150.)

A new version of this title is available

Update information - February 2020: A footnote was added to recommendation 1.3.17 on the potential risk of propranolol overdose in people with migraine who also have depression. November 2015: New and updated recommendations on the prophylactic treatment of migraine were added.

Update information - February 2020: A footnote was added to recommendation 1.3.17 on the potential risk of propranolol overdose in people with migraine who also have depression. November 2015: New and updated recommendations on the prophylactic treatment of migraine were added.

Headaches: Diagnosis and Management of Headaches in Young People and Adults [Internet].

Show details

Contents

< PrevNext >

Appendix PReferences

1.: Treatment of migraine. Practitioner. 1971;206(234):551–554. (Guideline Ref ID ANON1971) [PubMed: 4930722]
2.: Migraine treated with an antihistamine-analgesic combination. Practitioner. 1973;211(263):357–361. (Guideline Ref ID ANON1973) [PubMed: 4148490]
3.: Abbott RB, Hui KK, Hays RD, Li MD, Pan T. A randomized controlled trial of Tai Chi for tension headaches. Evidence-Based Complementary and Alternative Medicine. 2007;4(1):107–113. (Guideline Ref ID ABBOTT2007) [PMC free article: PMC1810369] [PubMed: 17342248]
4.: Abiusi GRP. Double blind clinical trial with lysine clonixinate plus ergotamine tartrate vs. aspirin in the treatment of headaches. Prensa Medica Argentina. 2000;87(10):1017–1023. (Guideline Ref ID ABIUSI2000)
5.: Abram HS, Buckloh LM, Schilling LM, Wiltrout SA, Ramirez-Garnica G, Turk WR. A randomized, controlled trial of a neurological and psychoeducational group appointment model for pediatric headaches. Children’s Health Care. 2007;36(3):249–265. (Guideline Ref ID ABRAM2007)
6.: Adam EI. A treatment for the acute migraine attack. Journal of International Medical Research. 1987;15(2):71–75. (Guideline Ref ID ADAM1987) [PubMed: 3556262]
7.: Adelman JU, Adelman LC, Von SR. Cost-effectiveness of antiepileptic drugs in migraine prophylaxis. Headache. 2002;42(10):978–983. (Guideline Ref ID ADELMAN2002) [PubMed: 12453029]
8.: Adelman JU, Von Seggern RL, Mannix LK. Migraine headaches: Implications for management from a nationwide patient survey. Headache Quarterly. 2000;11(2):105–112. (Guideline Ref ID ADELMAN2000)
9.: Afshari D, Rafizadeh S, Rezaei M. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis. International Journal of Neuroscience. 2012;122(2):60–68. (Guideline Ref ID AFSHARI2012) [PubMed: 21950578]
10.: Agro F, Liguori A, Petti FB, Cataldo R, Petitti T, Totonelli A. Acupuncture versus pharmacological therapy in the treatment of migraine without aura: Clinical results. Pain Clinic. 2005;17(2):245–247. (Guideline Ref ID AGRO2005)
11.: Ahmed MA, Martinez A, Cahill D, Chong K, Whitehouse WP. When to image neurologically normal children with headaches: development of a decision rule. Acta Paediatr. 2010;99(6):940–943. (Guideline Ref ID AHMED2010) [PubMed: 20178515]
12.: Ahonen E, Hakumaki M, Mahlamaki S, Partanen J, Riekkinen P, Sivenius J. Acupuncture and physiotherapy in the treatment of myogenic headache patients: pain relief and EMG activity. Advances Pain Research Therapy. 1983;5:571–576. (Guideline Ref ID AHONEN1983)
13.: Ahonen E, Hakumaki M, Mahlamaki S, Partanen J, Riekkinen P, Sivenius J. Effectiveness of acupuncture and physiotherapy on myogenic headache: a comparative study. Acupuncture Electro-Therapeutics Research. 1984;9(3):141–150. (Guideline Ref ID AHONEN1984) [PubMed: 6151786]
14.: Ahuja GK, Verma AK. Propranolol in prophylaxis of migraine. Indian Journal of Medical Research. 1985;82:263–265. (Guideline Ref ID AHUJA1985) [PubMed: 3908306]
15.: Akpek S, Arac M, Atilla S, Onal B, Yucel C, Isik S. Cost-effectiveness of computed tomography in the evaluation of patients with headache. Headache. 1995;35(4):228–230. (Guideline Ref ID AKPEK1995) [PubMed: 7775181]
16.: Alecrim-Andrade J, Antunes MJ, Carne X, Md, Magela SV, Rodrigues CF. Acupuncture in Migraine Prevention: A Randomized Sham Controlled Study With 6-months Posttreatment Follow-up. Clinical Journal of Pain. 2008;24(2):98–105. (Guideline Ref ID ALECRIMANDRADE2008) [PubMed: 18209514]
17.: Alehan FK. Value of neuroimaging in the evaluation of neurologically normal children with recurrent headache. Journal of Child Neurology. 2002;17(11):807–809. (Guideline Ref ID ALEHAN2002) [PubMed: 12585718]
18.: Allais G, De Lorenzo C, Quirico PE, Airola G, Tolardo G, Mana O, et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache. 2002;42(9):855–861. (Guideline Ref ID ALLAIS2002) [PubMed: 12390610]
19.: Allais G, Romoli M, Rolando S, Airola G, Castagnoli Gabellari I, Allais R, et al. Ear acupuncture in the treatment of migraine attacks: a randomized trial on the efficacy of appropriate versus inappropriate acupoints. Neurological Sciences. 2011;32 Suppl 1:S173–S175. (Guideline Ref ID ALLAIS2011) [PubMed: 21533739]
20.: Allen KD, Shriver MD. Role of parent-mediated pain behavior management strategies in biofeedback treatment of childhood migraines. Behavior Therapy. 1998;29(3):477–490. (Guideline Ref ID ALLEN1998)
21.: Altieri M, Di Giambattista R, Di Clemente L, Fagiolo D, Tarolla E, Mercurio A, et al. Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: a pilot study. Cephalalgia. 2009;29(3):293–299. (Guideline Ref ID ALTIERI2009) [PubMed: 19220310]
22.: Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118(1–2):92–96. (Guideline Ref ID AMBROSINI2005) [PubMed: 16202532]
23.: Anciano D. The development of a comprehensive headache diary--verbal descriptor scales. British Journal of Clinical Psychology. 1987;26(Pt 3):201–213. (Guideline Ref ID ANCIANO1987) [PubMed: 3664037]
24.: Andersson G, Lundstrom P, Strom L. Internet-based treatment of headache: does telephone contact add anything? Headache. 2003;43(4):353–361. (Guideline Ref ID ANDERSSON2003) [PubMed: 12656706]
25.: Andersson PG. BC-105 and deseril in migraine prophylaxis. (A double-blind study). Headache. 1973;13(2):68–73. (Guideline Ref ID ANDERSSON1973) [PubMed: 4578493]
26.: Andersson PG, Dahl S, Hansen JH. Prophylactic treatment of classical and non-classical migraine with metoprolol - a comparison with placebo. Cephalalgia. 1983;3(4):207–212. (Guideline Ref ID ANDERSSON1983) [PubMed: 6640652]
27.: Andersson PG, Jespersen LT. Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo. Cephalalgia. 1986;6(1):51–54. (Guideline Ref ID ANDERSSON1986A) [PubMed: 3516408]
28.: Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurological Sciences. 2007;28 Suppl 2:S70–S77. (Guideline Ref ID ANDRASIK2007) [PubMed: 17508184]
29.: Andrasik F, Blanchard EB, Neff DF, Rodichok LD. Biofeedback and relaxation training for chronic headache: a controlled comparison of booster treatments and regular contacts for long-term maintenance. Journal of Consulting & Clinical Psychology. 1984;52(4):609–615. (Guideline Ref ID ANDRASIK1984) [PubMed: 6381563]
30.: Andrasik F, Grazzi L, Usai S, Kass S, Bussone G. Disability in chronic migraine with medication overuse: treatment effects through 5 years. Cephalalgia. 2010;30(5):610–614. (Guideline Ref ID ANDRASIK2010) [PubMed: 19614686]
31.: Andrasik F, Holroyd KA. A test of specific and nonspecific effects in the biofeedback treatment of tension headache. Journal of Consulting & Clinical Psychology. 1980;48(5):575–586. (Guideline Ref ID ANDRASIK1980) [PubMed: 7410656]
32.: Andrasik F, Holroyd KA. Specific and nonspecific effects in the biofeedback treatment of tension headache: 3-year follow-up. Journal of Consulting & Clinical Psychology. 1983;51(4):634–636. (Guideline Ref ID ANDRASIK1983) [PubMed: 6619376]
33.: Andrasik F. Behavioral treatment of migraine: current status and future directions. Expert Review of Neurotherapeutics. 2004;4(3):403–413. (Guideline Ref ID ANDRASIK2004) [PubMed: 15853538]
34.: Ang SH, Chan YC, Mahadevan M. Emergency department headache admissions in an acute care hospital:why do they occur and what can we do about it? Annals of the Academy of Medicine. Singapore. 2009;38(11):1007–1010. (Guideline Ref ID ANG2009) [PubMed: 19956825]
35.: Anneken K, Evers S, Husstedt IW. Efficacy of fixed combinations of acetylsalicyclic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review. European Journal of Neurology. 2010;17(4):534–e25. [Review] [55 refs] (Guideline Ref ID ANNEKEN2010) [PubMed: 20074228]
36.: Ansell E, Fazzone T, Festenstein R, Johnson ES, Thavapalan M, Wilkinson M, et al. Nimodipine in migraine prophylaxis. Cephalalgia. 1988;8(4):269–272. (Guideline Ref ID ANSELL1988) [PubMed: 3064919]
37.: Anthony M, Lance JW. Indomethacin in migraine. Medical Journal of Australia. 1968;1(2):56–57. (Guideline Ref ID ANTHONY1968) [PubMed: 4867513]
38.: Anthony M, Lord GD, Lance JW. Controlled trials of cimetidine in migraine and cluster headache. Headache. 1978;18(5):261–264. (Guideline Ref ID ANTHONY1978) [PubMed: 363648]
39.: Antunes NL. The spectrum of neurologic disease in children with systemic cancer. Pediatric Neurology. 2001;25(3):227–235. (Guideline Ref ID ANTUNES2001) [PubMed: 11587878]
40.: Antunes NL, De Angelis LM. Neurologic consultations in children with systemic cancer. Pediatric Neurology. 1999;20(2):121–124. (Guideline Ref ID ANTUNES1999) [PubMed: 10082340]
41.: Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, et al. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache. 2008;48(7):1012–1025. (Guideline Ref ID APOSTOL2008) [PubMed: 18705027]
42.: Appelbaum KA, Blanchard EB, Nicholson NL, Radnitz C, Kirsch C, Michultka D, et al. Controlled evaluation of the addition of cognitive strategies to a home-based relaxation protocol for tension headache. Behavior Therapy. 1990;21(3):293–303. (Guideline Ref ID APPELBAUM1990)
43.: Arena JG, Bruno GM, Hannah SL, Meador KJ. A comparison of frontal electromyographic biofeedback training, trapezius electromyographic biofeedback training, and progressive muscle relaxation therapy in the treatment of tension headache. Headache. 1995;35(7):411–419. (Guideline Ref ID ARENA1995) [PubMed: 7672959]
44.: Argyriou AA, Chroni E, Polychronopoulos P, Argyriou K, Papapetropoulos S, Corcondilas M, et al. Headache characteristics and brain metastases prediction in cancer patients. European Journal of Cancer Care. 2006;15(1):90–95. (Guideline Ref ID ARGYRIOU2006) [PubMed: 16441682]
45.: Arthur GP, Hornabrook RW. The treatment of migraine with BC 105 (pizotifen): a double blind trial. New Zealand Medical Journal. 1971;73(464):5–9. (Guideline Ref ID ARTHUR1971) [PubMed: 4925988]
46.: Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F. Sodium Valproate versus Propranolol in paediatric migraine prophylaxis. European Journal of Paediatric Neurology. 2005;9(5):333–338. (Guideline Ref ID ASHRAFI2005) [PubMed: 16120482]
47.: Ashtari F, Shaygannejad V, Akbari M. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. Acta Neurologica Scandinavica. 2008;118(5):301–305. (Guideline Ref ID ASHTARI2008) [PubMed: 18713156]
48.: Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, et al. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Headache. 2011;51(4):507–517. (Guideline Ref ID AURORA2011A) [PubMed: 21457235]
49.: Aysun S, Yetuk M. Clinical experience on headache in children: analysis of 92 cases. Journal of Child Neurology. 1998;13(5):202–210. (Guideline Ref ID AYSUN1998) [PubMed: 9620010]
50.: Ayzenberg I, Katsarava Z, Mathalikov R, Chernysh M, Osipova V, Tabeeva G, et al. The burden of headache in Russia: validation of the diagnostic questionnaire in a population-based sample. European Journal of Neurology. 2011;18(3):454–459. (Guideline Ref ID AYZENBERG2011) [PubMed: 20722704]
51.: Azarpazhooh MR, Rafi S, Etemadi MM, Khadem N, Fazlinejad A. The relation between short-term oral contraceptive consumption and cerebrovascular, cardiovascular disorders in Iranian women attending Hajj. Saudi Medical Journal. 2008;29(7):1024–1027. (Guideline Ref ID AZARPAZHOOH2008) [PubMed: 18626534]
52.: Azzopardi TD, Brooks NA. Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine. Annals of Pharmacotherapy. 2008;42(3):397–402. [Review] [12 refs] (Guideline Ref ID AZZOPARDI2008) [PubMed: 18285561]
53.: Bademosi O, Osuntokun BO. Pizotifen in the management of migraine. Practitioner. 1978;220(1316):325–327. (Guideline Ref ID BADEMOSI1978) [PubMed: 345259]
54.: Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology. 2000;54(9):1832–1839. (Guideline Ref ID BAHRA2000) [PubMed: 10802793]
55.: Baker HL Jr. Cranial CT in the investigation of headache: cost-effectiveness for brain tumors. Journal of Neuroradiology. 1983;10(2):112–116. (Guideline Ref ID BAKER1983) [PubMed: 6410008]
56.: Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Pregnancy complications and delivery outcomes in pregnant women with severe migraine. Obstetrical and Gynecological Survey. 2008;63(2):79–81. (Guideline Ref ID BANHIDY2008)
57.: Bank J. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache. 1994;34(8):476–478. (Guideline Ref ID BANK1994) [PubMed: 7960733]
58.: Baos V, Ester F, Castellanos A, Nocea G, Caloto MT, Gerth WC, et al. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes. International Journal of Clinical Practice. 2005;59(3):281–286. (Guideline Ref ID BAOS2005) [PubMed: 15857323]
59.: Basler HD, Jakle C, Kroner-Herwig B. Cognitive-behavioral therapy for chronic headache at German pain centers. International Journal of Rehabilitation and Health. 1996;2(4):235–252. (Guideline Ref ID BASLER1996)
60.: Battistella PA, Ruffilli R, Cernetti R, Pettenazzo A, Baldin L, Bertoli S, et al. A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache. 1993;33(1):36–39. (Guideline Ref ID BATTISTELLA1993) [PubMed: 8436497]
61.: Battistella PA, Ruffilli R, Moro R, Fabiani M, Bertoli S, Antolini A, et al. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache. 1990;30(5):264–268. (Guideline Ref ID BATTISTELLA1990) [PubMed: 2191938]
62.: Behan PO. Pizotifen in the treatment of severe recurrent headache single and divided dose therapy compared. British Journal of Clinical Practice. 1982;36(1):13–17. (Guideline Ref ID BEHAN1982) [PubMed: 7082549]
63.: Behan PO, Reid M. Propranolol in the treatment of migraine. Practitioner. 1980;224(1340):201–203. (Guideline Ref ID BEHAN1980) [PubMed: 6988825]
64.: Bekkelund SI, Salvesen R. Patient satisfaction with a neurological specialist consultation for headache. Scandinavian Journal of Primary Health Care. 2002;20(3):157–160. (Guideline Ref ID BEKKELUND2002) [PubMed: 12389752]
65.: Bekkelund SI, Salvesen R. North Norway Headache Study (NNHS). Are headache patients who initiate their referral to a neurologist satisfied with the consultation? A population study of 927 patients--the North Norway Headache Study (NNHS). Family Practice. 2001;18(5):524–527. (Guideline Ref ID BEKKELUND2001) [PubMed: 11604376]
66.: Belam J, Harris G, Kernick D, Kline F, Lindley K, McWatt J, et al. A qualitative study of migraine involving patient researchers. British Journal of General Practice. 2005;55(511):87–93. (Guideline Ref ID BELAM2005) [PMC free article: PMC1463213] [PubMed: 15720928]
67.: Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 1989;39(4):590–592. (Guideline Ref ID BELGRADE1989) [PubMed: 2648190]
68.: Bell CF, Foley KA, Barlas S, Solomon G, Hu XH. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: A multicenter, prospective, open-label, two-attack, crossover study. Clinical Therapeutics. 2006;28(6):872–880. (Guideline Ref ID BELL2006) [PubMed: 16860170]
69.: Bell NW, Abramowitz SI, Folkins CH. Biofeedback, brief psychotherapy and tension headache. Headache. 1983;23(4):162–173. (Guideline Ref ID BELL1983) [PubMed: 6885408]
70.: Bell R, Montoya D, Shuaib A, Lee MA. A comparative trial of three agents in the treatment of acute migraine headache. Annals of Emergency Medicine. 1990;19(10):1079–1082. (Guideline Ref ID BELL1990) [PubMed: 2221511]
71.: Bellavance AJ, Meloche JP. A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis. Headache. 1990;30(11):710–715. (Guideline Ref ID BELLAVANCE1990) [PubMed: 2074163]
72.: Bendtsen L, Buchgreitz L, Ashina S, Jensen R. Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. European Journal of Neurology. 2007;14(2):187–193. (Guideline Ref ID BENDTSEN2007) [PubMed: 17250728]
73.: Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J, et al. EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. European Journal of Neurology. 2010;17(11):1318–1325. [Review] (Guideline Ref ID BENDTSEN2010A) [PubMed: 20482606]
74.: Benson MD, Rebar RW. Relationship of migraine headache and stroke to oral contraceptive use. Journal of Reproductive Medicine. 1986;31(12):1082–1088. (Guideline Ref ID BENSON1986) [PubMed: 3540297]
75.: Berger JR, Stein N, Pall L. Headache and human immunodeficiency virus infection: a case control study. European Neurology. 1996;36(4):229–233. (Guideline Ref ID BERGER1996) [PubMed: 8814427]
76.: Bettucci D, Testa L, Calzoni S, Mantegazza P, Viana M, Monaco F. Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: Evaluation of efficacy and impact on quality of life. Journal of Headache and Pain. 2006;7(1):34–36. (Guideline Ref ID BETTUCCI2006) [PMC free article: PMC3451576] [PubMed: 16514501]
77.: Bidabadi E, Mashouf M. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Paediatric Drugs. 2010;12(4):269–275. (Guideline Ref ID BIDABADI2010) [PubMed: 20593910]
78.: Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22(5):345–353. (Guideline Ref ID BIGAL2002A) [PubMed: 12110110]
79.: Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia. 2004;24(6):483–490. (Guideline Ref ID BIGAL2004) [PubMed: 15154858]
80.: Bigal ME, Tepper SJ, Dowson AJ. Tension-type headache. Headache: The Journal of Head & Face Pain. 2006;46(5):826–827. [Commentary on] Cerbo R, Centonze V, Grazioli I, Tavolato B, Trent T, Uslenghi C, Sternieri E. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicenter trial. Eur J Neurol. 2005;12:759–767. (Guideline Ref ID BIGAL2006)
81.: Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache. 1977;17(2):61–63. (Guideline Ref ID BILLE1977) [PubMed: 324951]
82.: Blanchard EB, Andrasik F, Arena JG, Neff DF, Jurish SE, Teders SJ, et al. Nonpharmacologic treatment of chronic headache: prediction of outcome. Neurology. 1983;33(12):1596–1603. (Guideline Ref ID BLANCHARD1983) [PubMed: 6358947]
83.: Blanchard EB, Andrasik F, Neff DF. Social validation of the headache diary. Behavior Therapy. 1981;12(5):711–715. (Guideline Ref ID BLANCHARD1981)
84.: Blanchard EB, Appelbaum KA, Nicholson NL, Radnitz CL, Morrill B, Michultka D, et al. A controlled evaluation of the addition of cognitive therapy to a home-based biofeedback and relaxation treatment of vascular headache. Headache. 1990;30(6):371–376. (Guideline Ref ID BLANCHARD1990) [PubMed: 2196240]
85.: Blanchard EB, Appelbaum KA, Radnitz CL, Michultka D, Morrill B, Kirsch C, et al. Placebo-controlled evaluation of abbreviated progressive muscle relaxation and of relaxation combined with cognitive therapy in the treatment of tension headache. Journal of Consulting & Clinical Psychology. 1990;58(2):210–215. (Guideline Ref ID BLANCHARD1990A) [PubMed: 2186066]
86.: Blanchard EB, Appelbaum KA, Radnitz CL, Morrill B, Michultka D, Kirsch C, et al. A controlled evaluation of thermal biofeedback and thermal biofeedback combined with cognitive therapy in the treatment of vascular headache. Journal of Consulting & Clinical Psychology. 1990;58(2):216–224. (Guideline Ref ID BLANCHARD1990B) [PubMed: 2186067]
87.: Blanchard EB, Nicholson NL, Radnitz CL, Steffek BD, Appelbaum KA, Dentinger MP. The role of home practice in thermal biofeedback. Journal of Consulting & Clinical Psychology. 1991;59(4):507–512. (Guideline Ref ID BLANCHARD1991) [PubMed: 1918553]
88.: Blanchard EB, Nicholson NL, Taylor AE, Steffek BD, Radnitz CL, Appelbaum KA. The role of regular home practice in the relaxation treatment of tension headache. Journal of Consulting & Clinical Psychology. 1991;59(3):467–470. (Guideline Ref ID BLANCHARD1991A) [PubMed: 2071733]
89.: Blanchard EB, Peters ML, Hermann C, Turner SM, Buckley TC, Barton K, et al. Direction of temperature control in the thermal biofeedback treatment of vascular headache. Applied Psychophysiology & Biofeedback. 1997;22(4):227–245. (Guideline Ref ID BLANCHARD1997) [PubMed: 9595177]
90.: Blanchard EB, Theobald DE, Williamson DA, Silver BV, Brown DA. Temperature biofeedback in the treatment of migraine headaches: a controlled evaluation. Archives of General Psychiatry. 1978;35(5):581–588. (Guideline Ref ID BLANCHARD1978) [PubMed: 365125]
91.: Blau JN, MacGregor EA. Migraine consultations: a triangle of viewpoints. Headache. 1995;35(2):104–106. (Guideline Ref ID BLAU1995) [PubMed: 7737860]
92.: Block GA, Goldstein J, Polis A, Reines SA, Smith ME. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups. Headache. 1998;38(10):764–771. (Guideline Ref ID BLOCK1998) [PubMed: 11284464]
93.: Boe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology. 2007;69(1):26–31. (Guideline Ref ID BOE2007) [PubMed: 17475943]
94.: Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia. 2009;29(8):855–863. (Guideline Ref ID BOE2009) [PubMed: 19228151]
95.: Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy. European Journal of Neurology. 2009;16(6):705–712. (Guideline Ref ID BOE2009A) [PubMed: 19236455]
96.: Boline P. Chiropractic and pharmaceutical treatment for chronic muscle tension headaches: a randomized clinical trail. Transactions of the Consortium for Chiropractic Research. 1992;7:45–47. (Guideline Ref ID BOLINE1992A)
97.: Boline P, Kassack K, Bronfort G, Nelson C, Anderson A. Spinal manipulation vs. amitriptyline for the treatment of chronic tension-type headaches: a randomized clinical trial. Journal of Manipulative and Physiological Therapeutics. 1995;18(3):148–154. (Guideline Ref ID BOLINE1995) [PubMed: 7790794]
98.: Bond DS, Digre KB, Rubingh C, Durrant L, Baggaley SK. Impact of a self-help intervention on performance of headache management behaviors: a self-efficacy approach. Internet Journal of Allied Health Sciences & Practice. 2004;2(1):1–15. (Guideline Ref ID BOND2004)
99.: Borges J, Zavaleta C. Study of a new analgesic compound in the treatment of tension headache. Journal of International Medical Research. 1976;4(1):74–78. (Guideline Ref ID BORGES1976) [PubMed: 799981]
100.: Borgesen SE, Nielsen JL, Moller CE. Prophylactic treatment of migraine with propranolol. A clinical trial. Acta Neurologica Scandinavica. 1974;50(5):651–656. (Guideline Ref ID BORGESEN1974) [PubMed: 4611129]
101.: Boureau F, Chazot G, Emile J, Bertin L, d’Allens H. Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group European. Neurology. 1995;35(5):264–269. (Guideline Ref ID BOUREAU1995) [PubMed: 8542914]
102.: Bove G, Nilsson N. Spinal manipulation in the treatment of episodic tension-type headache: a randomized controlled trial. Journal of the American Medical Association. 1998;280(18):1576–1579. (Guideline Ref ID BOVE1998) [PubMed: 9820258]
103.: Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M. Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients. Journal of Headache and Pain. 2003;4(2):72–78. (Guideline Ref ID BOZ2003)
104.: Brandes J, Poole A, Kallela M, Schreiber C, MacGregor E, Silberstein S, et al. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia. 2009;29(11):1133–1148. (Guideline Ref ID BRANDES2009) [PubMed: 19811503]
105.: Brandes JL, Kudrow D, Stark SR, O’Carroll CP, Adelman JU, O’Donnell FJ, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. Journal of the American Medical Association. 2007;297(13):1443–1454. (Guideline Ref ID BRANDES2007A) [PubMed: 17405970]
106.: Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for Migraine Prevention: A Randomized Controlled Trial. Journal of the American Medical Association. 2004;291(8):965–973. (Guideline Ref ID BRANDES2004) [PubMed: 14982912]
107.: Brew BJ, Miller J. Human immunodeficiency virus-related headache. Neurology. 1993;43(6):1098–1100. (Guideline Ref ID BREW1993) [PubMed: 8170549]
108.: Brighina F, Salemi G, Fierro B, Gasparro A, Balletta A, Aloisio A, et al. A validation study of an Italian version of the “ID Migraine” Headache. 2007;47(6):905–908. (Guideline Ref ID BRIGHINA2007) [PubMed: 17578542]
109.: Brighina F, Salemi G, Fierro B, Gasparro A, Balletta G, Aloisio A, et al. A validation study of an Italian version of the ID Migraine: preliminary results. Journal of Headache & Pain. 2005;6(4):216–219. (Guideline Ref ID BRIGHINA2005) [PMC free article: PMC3451999] [PubMed: 16362668]
110.: Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Annals of Emergency Medicine. 2004;43(2):256–262. (Guideline Ref ID BROUSSEAU2004) [PubMed: 14747817]
111.: Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller ID, Menzin J. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment. Headache. 2005;45(8):1012–1022. (Guideline Ref ID BROWN2005) [PubMed: 16109115]
112.: Brown JS, Papadopoulos G, Neumann PJ, Price M, Friedman M, Menzin J. Cost-effectiveness of migraine prevention: the case of topiramate in the UK. Cephalalgia. 2006;26(12):1473–1482. (Guideline Ref ID BROWN2006) [PubMed: 17116098]
113.: Brown JS, Rupnow MF, Neumann P, Friedman M, Menzin J. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update. Managed Care Interface. 2006;19(12):31–38. (Guideline Ref ID BROWN2006A) [PubMed: 17274479]
114.: Bruhn P, Olesen J, Melgaard B. Controlled trial of EMG feedback in muscle contraction headache. Annals of Neurology. 1979;6(1):34–36. (Guideline Ref ID BRUHN1979) [PubMed: 389148]
115.: Bryans R, Descarreaux M, Duranleau M, Marcoux H, Potter B, Ruegg R, et al. Evidence-based guidelines for the chiropractic treatment of adults with headache. Journal of Manipulative & Physiological Therapeutics. 2011;34(5):274–289. (Guideline Ref ID BRYANS2011) [PubMed: 21640251]
116.: Budzynski TH, Stoyva JM, Adler CS, Mullaney DJ. EMG biofeedback and tension headache: a controlled outcome study. Psychosomatic Medicine. 1973;35(6):484–496. (Guideline Ref ID BUDZYNSKI1973) [PubMed: 4764541]
117.: Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomedicine & Pharmacotherapy. 2002;56(6):283–288. (Guideline Ref ID BURKE2002) [PubMed: 12224599]
118.: Burton LJ, Quinn B, Pratt-Cheney JL, Pourani M. Headache etiology in a pediatric emergency department. Pediatric Emergency Care. 1997;13(1):1–4. (Guideline Ref ID BURTON1997) [PubMed: 9061724]
119.: Bussone G, Boiardi A, Merati B, Crenna P, Picco A. Chronic cluster headache: response to lithium treatment. Journal of Neurology. 1979;221(3):181–185. (Guideline Ref ID BUSSONE1979) [PubMed: 91671]
120.: Bussone G, Grazzi L, D’Amico D, Leone M, Andrasik F. Biofeedback-assisted relaxation training for young adolescents with tension-type headache: a controlled study. Cephalalgia. 1998;18(7):463–467. (Guideline Ref ID BUSSONE1998) [PubMed: 9793698]
121.: Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. 1990;30(7):411–417. (Guideline Ref ID BUSSONE1990) [PubMed: 2205598]
122.: Bussone G, Manzoni GC, Cortelli P, Roncolato M, Fabbri L, Benassuti C. Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks. Neurol Sci. 2000;21(5):272–278. (Guideline Ref ID BUSSONE2000) [PubMed: 11286039]
123.: Caccia MR. Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study. European Neurology. 1975;13(6):560–563. (Guideline Ref ID CACCIA1975) [PubMed: 1104361]
124.: Cady RK, Borchert LD, Spalding W, Hart CC, Sheftell FD. Simple and efficient recognition of migraine with 3-question headache screen. Headache. 2004;44(4):323–327. (Guideline Ref ID CADY2004) [PubMed: 15109356]
125.: Cady RK, Lipton RB, Hall C, Stewart WF, O’Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache. 2000;40(10):792–797. (Guideline Ref ID CADY2000) [PubMed: 11135022]
126.: Cady RK, Diamond ML, Diamond MP, Ballard JE, Lener ME, Dorner DP, et al. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. Headache. 2011;51(5):664–673. (Guideline Ref ID CADY2011A) [PubMed: 21521204]
127.: Cady RK, Martin VT, Geraud G, Rodgers A, Zhang Y, Ho AP, et al. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response. Headache. 2009;49(5):687–696. (Guideline Ref ID CADY2009) [PubMed: 19472447]
128.: Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178–1183. (Guideline Ref ID CALHOUN2007) [PubMed: 17883522]
129.: Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26(4):168–171. (Guideline Ref ID CALLAHAM1986) [PubMed: 3519528]
130.: Carleton SC, Shesser RF, Pietrzak MP, Chudnofsky CR, Starkman S, Morris DL, et al. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Annals of Emergency Medicine. 1998;32(2):129–138. (Guideline Ref ID CARLETON1998) [PubMed: 9701293]
131.: Carlsson J, Augustinsson LE, Blomstrand C, Sullivan M. Health status in patients with tension headache treated with acupuncture or physiotherapy. Headache. 1990;30(9):593–599. (Guideline Ref ID CARLSSON1990) [PubMed: 2262314]
132.: Carlsson J, Fahlcrantz A, Augustinsson LE. Muscle tenderness in tension headache treated with acupuncture or physiotherapy. Cephalalgia. 1990;10(3):131–141. (Guideline Ref ID CARLSSON1990A) [PubMed: 2245458]
133.: Caro G, Getsios D, Caro JJ, Raggio G, Burrows M, Black L. Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis. Cephalalgia. 2001;21(1):12–19. (Guideline Ref ID CARO2001) [PubMed: 11298658]
134.: Caro JJ, Getsios D, Raggio G, Caro G, Black L. Treatment of migraine in Canada with naratriptan: a cost-effectiveness analysis. Headache. 2001;41(5):456–464. (Guideline Ref ID CARO2001A) [PubMed: 11380643]
135.: Carroll JD, Maclay WP. Pizotifen (BC 105) in migraine prophylaxis. Current Medical Research & Opinion. 1975;3(2):68–71. (Guideline Ref ID CARROLL1975) [PubMed: 1095308]
136.: Cassina M, Di GE, Toldo I, Battistella PA, Clementi M. Migraine therapy during pregnancy and lactation. Expert Opinion on Drug Safety. 2010;9(6):937–948. (Guideline Ref ID CASSINA2010) [PubMed: 20662551]
137.: Castien RF, van der Windt DAWM, Grooten A, Dekker J. Effectiveness of manual therapy for chronic tension-type headache: a pragmatic, randomised, clinical trial. Cephalalgia. 2011;31(2):133–143. (Guideline Ref ID CASTIEN2011) [PubMed: 20647241]
138.: Ceccherelli F, Ambrosio F, Avila M, Duse G, Munari A, Giron GP. Acupuncture vs. placebo in the common migraine: a double blind study. Cephalalgia. 1987;7(Suppl 6):499–500. [abstract] (Guideline Ref ID CECCHERELLI1987)
139.: Cerbo R, Centonze V, Grazioli I, Tavolato B, Trenti T, Uslenghi C, et al. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial. European Journal of Neurology. 2005;12(10):759–767. (Guideline Ref ID CERBO2005) [PubMed: 16190913]
140.: Cerrato PL, Vernarec E. Acupuncture vs. Rx therapy for migraine prophylaxis. RN. 2003;66(3):26. (Guideline Ref ID CERRATO2003)
141.: Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia. 2005;25(3):199–204. (Guideline Ref ID CETE2005) [PubMed: 15689195]
142.: Chan TY, Wong V. Recurrent headache in chinese children: any agreement between clinician diagnosis and symptom-based diagnoses using the International Classification of Headache Disorders (Second Edition)? Journal of Child Neurology. 2006;21(2):132–138. (Guideline Ref ID CHAN2006) [PubMed: 16566877]
143.: Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999;318(7175):13–18. (Guideline Ref ID CHANG1999) [PMC free article: PMC27668] [PubMed: 9872876]
144.: Charlton RA, Cunnington MC, De Vries CS, Weil JG. Data resources for investigating drug exposure during pregnancy and associated outcomes: The General Practice Research Database (GPRD) as an alternative to pregnancy registries. Drug Safety. 2008;31(1):39–51. (Guideline Ref ID CHARLTON2008) [PubMed: 18095745]
145.: Chen BH. Lisinopril for migraine. Canadian Medical Association Journal. 2001;164(9):1337. (Guideline Ref ID CHEN2001)
146.: Chesney MA, Shelton JL. A comparison of muscle relaxation and electromyogram biofeedback treatments for muscle contraction headache. Journal of Behavioural Therapy & Experimental Psychiatry. 1976;7:221–225. (Guideline Ref ID CHESNEY1976)
147.: Chibnall JT, Duckro PN, Richardson WD. Physician frustration with chronic pain patients can and should be avoided. Headache Quarterly. 1995;6(2):123–125. (Guideline Ref ID CHIBNALL1995)
148.: Christiaans MH, Kelder JC, Arnoldus EPJ, Tijssen CC. Prediction of intracranial metastases in cancer patients with headache. Cancer. 2002;94(7):2063–2068. (Guideline Ref ID CHRISTIAANS2002) [PubMed: 11932910]
149.: Cicek M, Karcioglu O, Parlak I, Ozturk V, Duman O, Serinken M, et al. Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. Emergency Medicine Journal. 2004;21(3):323–326. (Guideline Ref ID CICEK2004) [PMC free article: PMC1726328] [PubMed: 15107371]
150.: Cittadini E, Goadsby PJ. Intranasal zolmitriptan is effective and well tolerated in acute cluster headache: A randomized placebo-controlled double-blind crossover study. Progress in Neurotherapeutics and Neuropsychopharmacology. 2008;3(1):127–135. (Guideline Ref ID CITTADINI2008)
151.: Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Archives of Neurology. 2006;63(11):1537–1542. (Guideline Ref ID CITTADINI2006) [PubMed: 16966497]
152.: Clarke CE, Edwards J, Nicholl DJ, Sivaguru A. Imaging results in a consecutive series of 530 new patients in the Birmingham Headache Service. J Neurol. 2010;257(8):1274–1278. (Guideline Ref ID CLARKE2010) [PubMed: 20198381]
153.: Clouston PD, DeAngelis LM, Posner JB. The spectrum of neurological disease in patients with systemic cancer. Annals of Neurology. 1992;31(3):268–273. (Guideline Ref ID CLOUSTON1992) [PubMed: 1637135]
154.: Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB. Efficacy of nonprescription doses of ibuprofen for treating migraine headache. a randomized controlled trial. Headache. 2001;41(7):665–679. (Guideline Ref ID CODISPOTI2001) [PubMed: 11554954]
155.: Coeytaux RR, Frasier PY, Reid A. Patient-centered outcomes for frequent headaches. Headache. 2007;47(4):480–485. (Guideline Ref ID COEYTAUX2007) [PubMed: 17445097]
156.: Coeytaux RR, Kaufman JS, Kaptchuk TJ, Chen W, Miller WC, Callahan LF, et al. A randomized, controlled trial of acupuncture for chronic daily headache. Headache. 2005;45(9):1113–1123. (Guideline Ref ID COEYTAUX2005) [PubMed: 16178942]
157.: Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. Journal of the American Medical Association. 2009;302(22):2451–2457. (Guideline Ref ID COHEN2009) [PubMed: 19996400]
158.: Cohen MJ, McArthur DL, Rickles WH. Comparison of four biofeedback treatments for migraine headache: physiological and headache variables. Psychosomatic Medicine. 1980;42(5):463–480. (Guideline Ref ID COHEN1980) [PubMed: 7008071]
159.: Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women. Associated risk factors. Journal of the American Medical Association. 1975;231(7):718–722. (Guideline Ref ID CGSSYM1975) [PubMed: 1172861]
160.: Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ. 2004;329(7479):1369–1373. (Guideline Ref ID COLMAN2004) [PMC free article: PMC535449] [PubMed: 15550401]
161.: Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature. Annals of Emergency Medicine. 2005;45(4):393–401. [Review] [31 refs] (Guideline Ref ID COLMAN2005) [PubMed: 15795718]
162.: Colman I, Friedman BW, Brown MD, Innes GD, Grafstein E, Roberts TE, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ. 2008;336(7657):1359–1361. (Guideline Ref ID COLMAN2008) [PMC free article: PMC2427093] [PubMed: 18541610]
163.: Conicella E, Raucci U, Vanacore N, Vigevano F, Reale A, Pirozzi N, et al. The child with headache in a pediatric emergency department. Headache. 2008;48(7):1005–1011. (Guideline Ref ID CONICELLA2008) [PubMed: 18705026]
164.: Conner SJ, Rideout S. What are the best therapies for acute migraine in pregnancy? Journal of Family Practice. 2005;54(11):992–995. (Guideline Ref ID CONNER2005) [PubMed: 16266607]
165.: Contag SA, Bushnell C. Contemporary management of migrainous disorders in pregnancy. Current Opinion in Obstetrics and Gynecology. 2010;22(6):437–445. (Guideline Ref ID CONTAG2010) [PubMed: 20930632]
166.: Cook NR, Bensenor IM, Lotufo PA, Lee IM, Skerrett PJ, Chown MJ, et al. Migraine and coronary heart disease in women and men. Headache. 2002;42(8):715–727. (Guideline Ref ID COOK2002) [PubMed: 12390634]
167.: Couch JR. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache. 2011;51(1):33–51. (Guideline Ref ID COUCH2011) [PubMed: 21070231]
168.: Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Archives of Neurology. 1979;36(11):695–699. (Guideline Ref ID COUCH1979) [PubMed: 508127]
169.: Cousins G, Hijazze S, Van De Laar FA, Fahey T. Diagnostic Accuracy of the ID Migraine: A Systematic Review and Meta-Analysis. Headache. 2011;51(7):1140–1148. (Guideline Ref ID COUSINS2011) [PubMed: 21649653]
170.: Cox DJ, Freundlich A, Meyer RG. Differential effectiveness of electromyograph feedback, verbal relaxation instructions, and medication placebo with tension headaches. Journal of Consulting and Clinical Psychology. 1975;43(6):892–898. (Guideline Ref ID COX1975) [PubMed: 1104671]
171.: Cram JR. EMG biofeedback and the treatment of tension headaches: A systematic analysis of treatment components. Behavior Therapy. 1980;11(5):699–710. (Guideline Ref ID CRAM1980)
172.: Crawford P, Simmons M. What dietary modifications are indicated for migraines? Journal of Family Practice. 2006;55(1):62, 63–66. (Guideline Ref ID CRAWFORD2006) [PubMed: 16388771]
173.: Creac’h C, Frappe P, Cancade M, Laurent B, Peyron R, Demarquay G, et al. In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial. Cephalalgia. 2011;31(11):1189–1198. (Guideline Ref ID CREACH2011) [PubMed: 21700646]
174.: CROOKS J, STEPHEN SA, BRASS W. Clinical trial of inhaled ergotamine tartrate in migraine. British Medical Journal. 1964;1(5377):221–224. (Guideline Ref ID CROOKS1964) [PMC free article: PMC1813133] [PubMed: 14074180]
175.: Cull RE. Investigation of late-onset migraine. Scottish Medical Journal. 1995;40(2):50–52. (Guideline Ref ID CULL1995) [PubMed: 7618069]
176.: Cull RE, Price WH, Dunbar A. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache. Journal of Neurology, Neurosurgery and Psychiatry. 1997;62(5):490–495. (Guideline Ref ID CULL1997) [PMC free article: PMC486861] [PubMed: 9153607]
177.: Cunnington MC, Ephross S. Results from an international observational study of pregnancy outcomes following exposure to sumatriptan, naratriptan or treximet. Cephalalgia. 2009;29:91. (Guideline Ref ID CUNNINGTON2009A)
178.: Cunnington M, Ephross S, Churchill P. The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Headache. 2009;49(10):1414–1422. (Guideline Ref ID CUNNINGTON2009) [PubMed: 19804390]
179.: Curtis KM, Mohllajee AP, Peterson HB. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception. 2006;73(2):189–194. (Guideline Ref ID CURTIS2006) [PubMed: 16413849]
180.: Curtis L. Unit costs of health and social care. Canterbury: Personal Social Services Reseach Unit, University of Kent; 2010. Available from: http://www.pssru.ac.uk/pdf/uc/uc2010/uc2010.pdf. (Guideline Ref ID CURTIS2010)
181.: Cutler N, Mushet GR, Davis R, Clements B, Whitcher L. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Neurology. 1995;45(8 Suppl 7):S5–S9. (Guideline Ref ID CUTLER1995) [PubMed: 7644082]
182.: D’Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial. Annals of Behavioral Medicine. 2008;36(1):21–32. (Guideline Ref ID DSOUZA2008) [PMC free article: PMC2931412] [PubMed: 18696172]
183.: Dahlof CG, Jacobs LD. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia. 1996;16(2):117–123. (Guideline Ref ID DAHLOF1996) [PubMed: 8665578]
184.: Dalsgaard-Nielsen T. Therapeutic results of prophylactic treatment for ‘classic’ migraine with antaminic substance (B P 400 Sandoz). Headache. 1968;8(1):6–15. (Guideline Ref ID DALSGAARDNIELSEN1968) [PubMed: 4384742]
185.: Daly EJ, Donn PA, Galliher MJ, Zimmerman JS. Biofeedback applications to migraine and tension headaches: A double-blinded outcome study. Biofeedback and Self-Regulation. 1983;8(1):135–152. (Guideline Ref ID DALY1983) [PubMed: 6882811]
186.: Daly EJ, Zimmerman JS, Donn PA, Galliher MJ. Psychophysiological treatment of migraine and tension headaches: A 12-month follow-up. Rehabilitation Psychology. 1985;30(1):3–10. (Guideline Ref ID DALY1985)
187.: Davis CP, Torre PR, Williams C, Gray C, Barrett K, Krucke G, et al. Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients. American Journal of Emergency Medicine. 1995;13(2):146–150. (Guideline Ref ID DAVIS1995) [PubMed: 7893296]
188.: de Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache. 1995;35(5):264–268. (Guideline Ref ID DEBENEDITTIS1995) [PubMed: 7775189]
189.: De Pinto O, Greene R. Methysergide for migraine. Practitioner. 1967;198(183):129–134. (Guideline Ref ID DEPINTO1967) [PubMed: 5341296]
190.: Demaerel P, Boelaert I, Wilms G, Baert AL. The role of cranial computed tomography in the diagnostic work-up of headache. Headache. 1996;36(6):347–348. (Guideline Ref ID DEMAEREL1996) [PubMed: 8707550]
191.: Descombes S, Brefel-Courbon C, Thalamas C, Albucher JF, Rascol O, Montastruc JL, et al. Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache. 2001;41(2):178–182. (Guideline Ref ID DESCOMBES2001) [PubMed: 11251703]
192.: Devineni T, Blanchard EB. A randomized controlled trial of an internet-based treatment for chronic headache. Behaviour Research & Therapy. 2005;43(3):277–292. (Guideline Ref ID DEVINENI2005) [PubMed: 15680926]
193.: Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, et al. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache. 2003;43(8):835–844. (Guideline Ref ID DIMONDA2003) [PubMed: 12940804]
194.: Di Piero V, Altieri M, Conserva G, Petolicchio B, Di CL, Hettiarachchi J, et al. The effects of a sensitisation campaign on unrecognised migraine: the Casilino study. Journal of Headache & Pain. 2007;8(4):205–208. (Guideline Ref ID DIPIERO2007) [PMC free article: PMC3451666] [PubMed: 17901925]
195.: Di Sabato F, Fusco BM, Pelaia P, Giacovazzo M. Hyperbaric oxygen therapy in cluster headache. Pain. 1993;52(2):243–245. (Guideline Ref ID DISABATO1993) [PubMed: 8455970]
196.: Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Clinica Terapeutica. 2000;151(3):145–148. (Guideline Ref ID DITRAPANI2000) [PubMed: 10958046]
197.: Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC. Topiramate improves health-related quality of life when used to prevent migraine. Headache. 2005;45(8):1023–1030. (Guideline Ref ID DIAMOND2005) [PubMed: 16109116]
198.: Diamond ML, Wenzel RG, Nissan GR. Optimizing migraine therapy: evidence-based and patient-centered care. Expert Review of Neurotherapeutics. 2006;6(6):911–919. [Review] [56 refs] (Guideline Ref ID DIAMOND2006) [PubMed: 16784413]
199.: Diamond S. Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial. Headache. 1976;15(4):282–287. (Guideline Ref ID DIAMOND1976) [PubMed: 1107267]
200.: Diamond S. Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache. 1983;23(5):206–210. (Guideline Ref ID DIAMOND1983) [PubMed: 6355010]
201.: Diamond S. Caffeine as an analgesic adjuvant in the treatment of headache. Headache Quarterly. 1999;10(2):119–125. (Guideline Ref ID DIAMOND1999)
202.: Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. Clinical Pharmacology & Therapeutics. 2000;68(3):312–319. (Guideline Ref ID DIAMOND2000) [PubMed: 11014413]
203.: Diamond S, Baltes BJ. Chronic tension headache--treated with amitriptyline--a double-blind study. Headache. 1971;11(3):110–116. (Guideline Ref ID DIAMOND1971) [PubMed: 4940167]
204.: Diamond S, Kudrow L, Stevens J, Shapiro DB. Long-term study of propranolol in the treatment of migraine. Headache. 1982;22(6):268–271. (Guideline Ref ID DIAMOND1982) [PubMed: 7174304]
205.: Diamond S, Medina JL. Controlled study of prophylaxis of migraine with propranolol. Clin Pharmacol Ther. 1975;17(2):232. (Guideline Ref ID DIAMOND1975)
206.: Diav-Citrin O, Shechtman S, Halberstadt Y, Finkel-Pekarsky V, Wajnberg R, Arnon J, et al. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reproductive Toxicology. 2011;31(4):540–545. (Guideline Ref ID DIAVCITRIN2011) [PubMed: 21338666]
207.: Dib M, Massiou H, Weber M, Henry P, Garcia-Acosta S, Bousser M. Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. Headache: The Journal of Head & Face Pain. 2003;43(3):299. (Guideline Ref ID DIB2003)
208.: Dib M, Massiou H, Weber M, Henry P, Garcia-Acosta S, Bousser MG, et al. Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. Neurology. 2002;58(11):1660–1665. (Guideline Ref ID DIB2002) [PubMed: 12058095]
209.: Diener H, Jansen J, Reches A, Pascual J, Pitei D, Steiner T. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Headache: The Journal of Head & Face Pain. 2003;43(3):301. (Guideline Ref ID DIENER2003A) [PubMed: 11844898]
210.: Diener HC. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group. Cephalalgia. 1999;19(6):581–588. (Guideline Ref ID DIENER1999) [PubMed: 10448545]
211.: Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, et al. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurology. 2007;6(12):1054–1062. (Guideline Ref ID DIENER2007) [PubMed: 17988947]
212.: Diener HC, Barbanti P, Dahlof C, Reuter U, Habeck J, Podhorna J. BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study. Cephalalgia. 2011;31(5):573–584. (Guideline Ref ID DIENER2011) [PubMed: 21172952]
213.: Diener HC, Bussone G, de LH, Eikermann A, Englert R, Floeter T, et al. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia. 2004;24(11):947–954. (Guideline Ref ID DIENER2004) [PubMed: 15482357]
214.: Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Erratum: Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(8):962. (Cephalalgia (2007) 27 (814–823)) (Guideline Ref ID DIENER2007B) [PubMed: 17441971]
215.: Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(7):814–823. (Guideline Ref ID DIENER2007A) [PubMed: 17441971]
216.: Diener HC, Eikermann A, Gessner U, Gobel H, Haag G, Lange R, et al. Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. European Neurology. 2004;52(1):50–56. (Guideline Ref ID DIENER2004B) [PubMed: 15240983]
217.: Diener HC, Foh M, Iaccarino C, Wessely P, Isler H, Strenge H, et al. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group. Cephalalgia. 1996;16(6):441–447. (Guideline Ref ID DIENER1996) [PubMed: 8902255]
218.: Diener HC, Gendolla A, Feuersenger A, Evers S, Straube A, Schumacher H, et al. Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial. Cephalalgia. 2009;29(9):921–927. (Guideline Ref ID DIENER2009A) [PubMed: 19250283]
219.: Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ, et al. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. European Neurology. 2002;47(2):99–107. (Guideline Ref ID DIENER2002A) [PubMed: 11844898]
220.: Diener HC, Katsarava Z. Medication overuse headache. Current Medical Research and Opinion. 2001;17 Suppl 1:s17–s21. (Guideline Ref ID DIENER2001) [PubMed: 12463272]
221.: Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurology. 2006;5(4):310–316. (Guideline Ref ID DIENER2006) [PubMed: 16545747]
222.: Diener HC, Krupp P, Schmitt T, Steitz G, Milde K, Freytag S. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Cephalalgia. 2001;21(1):66–70. (Guideline Ref ID DIENER2001A) [PubMed: 11298666]
223.: Diener HC, Peil H, Aicher B. The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2011;31(14):1466–1476. (Guideline Ref ID DIENER2011B) [PubMed: 21908446]
224.: Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2005;25(10):776–787. (Guideline Ref ID DIENER2005) [PubMed: 16162254]
225.: Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJA, Sandrini G, Wang SJ, et al. Topiramate in migraine prophylaxis: Results from a placebo-controlled trial with propranolol as an active control. Journal of Neurology. 2004;251(8):943–950. (Guideline Ref ID DIENER2004A) [PubMed: 15316798]
226.: Diener H-C, Pfaffenrath V, Pageler L, Peil H, Aicher B. [Triple combination (Thomapyrin) is more efficient for the treatment of headache than mono substances and dual combination]. Nervenheilkunde. 2005;24(7):626–639. (Guideline Ref ID DIENER2005C)
227.: Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, et al. The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache. 2007;47(10):1398–1408. (Guideline Ref ID DODICK2007) [PubMed: 18052949]
228.: Domingues RB, Piraja Da Silva AL, Domingues SA, Aquino CCH, Kuster GW. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arquivos De Neuro-Psiquiatria. 2009;67(4):973–977. (Guideline Ref ID DOMINGUES2009) [PubMed: 20069203]
229.: Donaldson D, Sundermann R, Jackson R, Bastani A. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial. American Journal of Emergency Medicine. 2008;26(2):124–130. (Guideline Ref ID DONALDSON2008) [PubMed: 18272089]
230.: Donkin RD, Parkin-Smith GF, Gomes AN. Possible effect of chiropractic manipulation and combined manual traction and manipulation on tension-type headache. Journal of the Neuromusculoskeletal System. 2002;10(3):89–97. (Guideline Ref ID DONKIN2002)
231.: Dooley M, Faulds D. Rizatriptan. A review of its efficacy in the management of migraine. Drugs. 1999;58(4):699–723. (Guideline Ref ID DOOLEY1999) [PubMed: 10551439]
232.: Dousset V, Laporte A, Legoff M, Traineau MH, Dartigues JF, Brochet B. Validation of a brief self-administered questionnaire for cluster headache screening in a tertiary center. Headache. 2009;49(1):64–70. (Guideline Ref ID DOUSSET2009) [PubMed: 19133334]
233.: Dowson A, Ball K, Haworth D. Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study. Curr Med Res Opin. 2000;16(3):190–197. (Guideline Ref ID DOWSON2000) [PubMed: 11191009]
234.: Dowson A, Jagger S. The UK Migraine Patient Survey: qualify of life and treatment. Current Medical Research and Opinion. 1999;15(4):241–253. (Guideline Ref ID DOWSON1999) [PubMed: 10640257]
235.: Dowson AJ, Mathew NT, Pascual J. Review of clinical trials using early acute intervention with oral triptans for migraine management. International Journal of Clinical Practice. 2006;60(6):698–706. [Review] [54 refs] (Guideline Ref ID DOWSON2006) [PubMed: 16805756]
236.: Dowson DI, Lewith GT, Machin D. The effects of acupuncture versus placebo in the treatment of headache. Pain. 1985;21(1):35–42. (Guideline Ref ID DOWSON1985) [PubMed: 3982837]
237.: Drummond PD. Effectiveness of methysergide in relation to clinical features of migraine. Headache. 1985;25(3):145–146. (Guideline Ref ID DRUMMOND1985A) [PubMed: 3891683]
238.: Drummond PD, Anthony M. Extracranial vascular responses to sublingual nitroglycerin and oxygen inhalation in cluster headache patients. Headache. 1985;25(2):70–74. (Guideline Ref ID DRUMMOND1985) [PubMed: 3921490]
239.: Drury RL, DeRisi WJ, Liberman RP. Temperature biofeedback treatment for migraine headache: a controlled multiple baseline study. Headache. 1979;19(5):278–284. (Guideline Ref ID DRURY1979) [PubMed: 381252]
240.: Duarte C, Dunaway F, Turner L, Aldag J, Frederick R. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial. Annals of Emergency Medicine. 1992;21(9):1116–1121. (Guideline Ref ID DUARTE1992) [PubMed: 1514724]
241.: Duarte J, Sempere AP, Delgado JA, Naranjo G, Sevillano MD, Claveria LE. Headache of recent onset in adults: a prospective population-based study. Acta Neurologica Scandinavica. 1996;94(1):67–70. (Guideline Ref ID DUARTE1996) [PubMed: 8874597]
242.: Duong S, Bozzo P, Nordeng H, Einarson A. Safety of triptans for migraine headaches during pregnancy and breastfeeding. Canadian Family Physician. 2010;56(6):537–539. (Guideline Ref ID DUONG2010) [PMC free article: PMC2902939] [PubMed: 20547518]
243.: Dutto L, Meineri P, Melchio R, Bracco C, Lauria G, Sciolla A, et al. Nontraumatic headaches in the emergency department: evaluation of a clinical pathway. Headache. 2009;49(8):1174–1185. (Guideline Ref ID DUTTO2009) [PubMed: 19619242]
244.: Ebneshahidi NS, Heshmatipour M, Moghaddami A, Eghtesadi-Araghi P. The effects of laser acupuncture on chronic tension headache - a randomised controlled trial. Acupuncture in Medicine. 2005;23(1):13–18. (Guideline Ref ID EBNESHAHIDI2005) [PubMed: 15844435]
245.: Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41(10):976–980. (Guideline Ref ID EDWARDS2001) [PubMed: 11903525]
246.: Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J. Topiramate in the preventive treatment of episodic migraine: A combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectrums. 2003;8(6):428–432. (Guideline Ref ID EDWARDS2003) [PubMed: 12858132]
247.: Eftedal OS, Lydersen S, Helde G, White L, Brubakk AO, Stovner LJ. A randomized, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia. 2004;24(8):639–644. (Guideline Ref ID EFTEDAL2004) [PubMed: 15265052]
248.: Eiland LS. Anticonvulsant use for prophylaxis of the pediatric migraine. Journal of Pediatric Health Care. 2007;21(6):392–395. (Guideline Ref ID EILAND2007) [PubMed: 17980806]
249.: Ekbom K. Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neurologica Scandinavica. 1969;45(5):601–610. (Guideline Ref ID EKBOM1969) [PubMed: 4391566]
250.: Ekbom K. Alprenolol for migraine prophylaxis. Headache. 1975;15(2):129–132. (Guideline Ref ID EKBOM1975) [PubMed: 1097368]
251.: Ekbom K, Lundberg PO. Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis. Headache. 1972;12(1):15–17. (Guideline Ref ID EKBOM1972) [PubMed: 4402287]
252.: Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurologica Scandinavica. 1993;88(1):63–69. (Guideline Ref ID EKBOM1993) [PubMed: 8396833]
253.: Ekbom K, Waldenlind E, Levi R, Andersson B, Boivie J, Dizdar N, et al. Treatment of acute cluster headache with sumatriptan. New England Journal of Medicine. 1991;325(5):322–326. (Guideline Ref ID EKBOM1991)
254.: El Amrani MG. A negative trial of sodium valproate in cluster headache: Methodological issues. Cephalalgia. 2002;22(3):205–208. (Guideline Ref ID ELAMRANI2002) [PubMed: 12047460]
255.: Elkharrat D, Raphael JC, Korach JM, Jars-Guincestre MC, Chastang C, Harboun C, et al. Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy. Intensive Care Medicine. 1991;17(5):289–292. (Guideline Ref ID ELKHARRAT1991) [PubMed: 1939875]
256.: Ellawela SA, Miller S, Mckenzie M, Gorrie G, Tyagi A. A study of the neuroimaging profile of patients referred to a specialist headache clinic. Journal of Headache and Pain. 2010;11:S130. (Guideline Ref ID ELLAWELA2010)
257.: Elliot S, Kernick D. Why do GPs with a special interest in headache investigate headache presentations with neuroradiology and what do they find? J Headache Pain. 2011. (Guideline Ref ID ELLIOT2011) [PMC free article: PMC3208048] [PubMed: 21956455]
258.: Ellis GL, Delaney J, DeHart DA, Owens A. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med. 1993;22(2):191–195. (Guideline Ref ID ELLIS1993) [PubMed: 8427430]
259.: Endres HG, Böwing G, Diener HC, Lange S, Maier C, Molsberger A, et al. Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial. The Journal of Headache and Pain. 2007;8(5):306–314. (Guideline Ref ID ENDRES2007) [PMC free article: PMC3476149] [PubMed: 17955168]
260.: Engel JM, Rapoff MA. Biofeedback-assisted relaxation training for adult and pediatric headache disorders. Occupational Therapy Journal of Research. 1990;10(5):283–299. (Guideline Ref ID ENGEL1990)
261.: Ergun H, Gulmez SE, Tulunay FC. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis. European Neurology. 2007;58(4):215–217. (Guideline Ref ID ERGUN2007) [PubMed: 17827966]
262.: Ernst E. Chiropractic manipulation not useful for tension-type headache. Focus on Alternative and Complementary Therapies. 1999;4(2):76–77. (Guideline Ref ID ERNST1999)
263.: Ertas M, Baykan B, Tuncel D, Gokce M, Gokcay F, Sirin H, et al. A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics. Cephalalgia. 2009;29(1):68–75. (Guideline Ref ID ERTAS2009) [PubMed: 18771489]
264.: Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330(7482):63–65. (Guideline Ref ID ETMINAN2005) [PMC free article: PMC543862] [PubMed: 15596418]
265.: Evans KW, Boan JA, Evans JL, Shuaib A. Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine. Pharmacoeconomics. 1997;12(5):565–577. (Guideline Ref ID EVANS1997) [PubMed: 10174323]
266.: Evers S, Frese A. Recent advances in the treatment of headaches. Current Opinion in Anaesthesiology. 2005;18(5):563–568. (Guideline Ref ID EVERS2005) [PubMed: 16534293]
267.: Evers S, Jensen R. Treatment of medication overuse headache - guideline of the EFNS headache panel. European Journal of Neurology. 2011;18(9):1115–1121. (Guideline Ref ID EVERS2011) [PubMed: 21834901]
268.: Evers S, Wibbeke B, Reichelt D, Suhr B, Brilla R, Husstedt I. The impact of HIV infection on primary headache. Unexpected findings from retrospective, cross-sectional, and prospective analyses. Pain. 2000;85(1–2):191–200. (Guideline Ref ID EVERS2000) [PubMed: 10692618]
269.: Facco E, Liguori A, Petti F, Zanette G, Coluzzi F, De Nardin M, et al. Traditional acupuncture in migraine: a controlled, randomized study. Headache. 2008;48(3):398–407. (Guideline Ref ID FACCO2008) [PubMed: 17868354]
270.: Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002;22(8):633–658. [Erratum appears in Cephalalgia. 2003 Feb;23(1):71] (Guideline Ref ID FERRARI2002) [PubMed: 12383060]
271.: Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(9294):1668–1675. (Guideline Ref ID FERRARI2001) [PubMed: 11728541]
272.: Fichtel A, Larsson B. Relaxation treatment administered by school nurses to adolescents with recurrent headaches. Headache. 2004;44(6):545–554. (Guideline Ref ID FICHTEL2004) [PubMed: 15186298]
273.: Fiesseler FW, Shih R, Szucs P, Silverman ME, Eskin B, Clement M, et al. Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial. Journal of Emergency Medicine. 2011;40(4):463–468. (Guideline Ref ID FIESSELER2011) [PubMed: 19846269]
274.: Fodden DI, Peatfield RC, Milsom PL. Beware the patient with a headache in the accident and emergency department. Archives of Emergency Medicine. 1989;6(1):7–12. (Guideline Ref ID FODDEN1989) [PMC free article: PMC1285550] [PubMed: 2712991]
275.: Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol. 1985;42(4):362–363. (Guideline Ref ID FOGAN1985) [PubMed: 3885921]
276.: Foldes EG. Comparative treatment study of migraine headache. International Journal of Clinical Pharmacology, Therapy & Toxicology. 1972;6(1):60–66. (Guideline Ref ID FOLDES1972) [PubMed: 4558785]
277.: Fontanillas N, Colas R, Munoz P, Oterino A, Pascual J. Long-term evolution of chronic daily headache with medication overuse in the general population. Headache. 2010;50(6):981–988. (Guideline Ref ID FONTANILLAS2010) [PubMed: 20236336]
278.: Forssman B, Henriksson KG, Kihlstrand S. A comparison between BC 105 and methysergide in the prophylaxis of migraine. Acta Neurologica Scandinavica. 1972;48(2):204–212. (Guideline Ref ID FORSSMAN1972) [PubMed: 4556413]
279.: Forssman B, Lindblad CJ, Zbornikova V. Atenolol for migraine prophylaxis. Headache. 1983;23(4):188–190. (Guideline Ref ID FORSSMAN1983) [PubMed: 6350226]
280.: Forsythe WI, Gillies D, Sills MA. Propanolol (‘Inderal’) in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26(6):737–741. (Guideline Ref ID FORSYTHE1984) [PubMed: 6519358]
281.: Foster KA, Liskin J, Cen S, Abbott A, Armisen V, Globe D, et al. The Trager approach in the treatment of chronic headache: a pilot study. Alternative Therapies in Health and Medicine. 2004;10(5):40–46. (Guideline Ref ID FOSTER2004) [PubMed: 15478785]
282.: Fox AW. Sumatriptan and pregnancy outcome. Headache. 2000;40(10):860–861. (Guideline Ref ID FOX2000) [PubMed: 11135036]
283.: Fox AW. Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure. Headache. 2004;44(8):842–843. (Guideline Ref ID FOX2004) [PubMed: 15330843]
284.: Fox AW, Chambers CD, Anderson PO, Diamond ML, Spierings ELH. Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache. 2002;42(1):8–15. (Guideline Ref ID FOX2002) [PubMed: 12005279]
285.: Frampton JE. Needle-free subcutaneous sumatriptan: In the acute treatment of migraine attacks or cluster headache episodes. CNS Drugs. 2011;25(11):983–994. (Guideline Ref ID FRAMPTON2011) [PubMed: 22054121]
286.: Frederick RC. Parenteral NSAIDs in the treatment of migraine cephalalgia. Headache Quarterly. 1997;8(3):219–223. (Guideline Ref ID FREDERICK1997)
287.: Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobieranda F. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Headache. 2008;48(6):921–930. (Guideline Ref ID FREITAG2008A) [PubMed: 18572432]
288.: Freitag FG. The acute treatment of migraine with transnasal butorphanol (TNB). Headache Quarterly. 1993;4(SUPPL 3):22–28. (Guideline Ref ID FREITAG1993)
289.: Freitag FG, Cady R, DiSerio F, Elkind A, Gallagher RM, Goldstein J, et al. Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache. 2001;41(4):391–398. (Guideline Ref ID FREITAG2001A) [PubMed: 11318886]
290.: Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58(11):1652–1659. (Guideline Ref ID FREITAG2002) [PubMed: 12058094]
291.: Freitag FG, Diamond S. Nadolol and placebo comparison study in the prophylactic treatment of migraine. Journal of the American Osteopathic Association. 1984;84(4):343–347. (Guideline Ref ID FREITAG1984) [PubMed: 6150909]
292.: French DJ, Gauthier JG, Roberge C, Bouchard S, Nouwen A. Self-efficacy in the thermal biofeedback treatment of migraine sufferers. Behavior Therapy. 1997;28(1):109–125. (Guideline Ref ID FRENCH1997)
293.: Friedman AP. Assessment of Fiorinal with Codeine in the treatment of tension headache. Clinical Therapeutics. 1986;8(6):703–721. (Guideline Ref ID FRIEDMAN1986) [PubMed: 3791366]
294.: Friedman AP, Boyles WF, Elkind AH, Fillingim J, Ford RG, Gallagher RM, et al. Fiorinal with codeine in the treatment of tension headache--the contribution of components to the combination drug. Clinical Therapeutics. 1988;10(3):303–315. (Guideline Ref ID FRIEDMAN1988) [PubMed: 3078909]
295.: Friedman AP, DiSerio FJ. Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine. Clinical Therapeutics. 1987;10(1):69–81. (Guideline Ref ID FRIEDMAN1987) [PubMed: 3329967]
296.: Friedman BW, Corbo J, Lipton RB, Bijur PE, Esses D, Solorzano C, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology. 2005;64(3):463–468. (Guideline Ref ID FRIEDMAN2005) [PubMed: 15699376]
297.: Friedman BW, Greenwald P, Bania TC, Esses D, Hochberg M, Solorzano C, et al. Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology. 2007;69(22):2038–2044. (Guideline Ref ID FRIEDMAN2007) [PubMed: 17942818]
298.: Friedman BW, Hochberg M, Esses D, Bijur PE, Corbo J, Paternoster J, et al. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines. Headache. 2006;46(6):934–941. (Guideline Ref ID FRIEDMAN2006) [PubMed: 16732839]
299.: Friedman BW, Kapoor A, Friedman MS, Hochberg ML, Rowe BH. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Annals of Emergency Medicine. 2008;52(6):705–713. [Review] [29 refs] (Guideline Ref ID FRIEDMAN2008) [PMC free article: PMC2587513] [PubMed: 18632186]
300.: Frishberg BM. The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations. Neurology. 1994;44(7):1191–1197. (Guideline Ref ID FRISHBERG1994) [PubMed: 8035914]
301.: Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. European Neurology. 2001;45(4):229–235. (Guideline Ref ID FRITSCHE2001) [PubMed: 11385260]
302.: Gabrielidou P, Lekkou G, Robotis A, Papatriantafillou J, Manias P, Karagiannis V, et al. Venlafaxine versus amitriptyline for the prophylaxis of tension type headache. Functional Neurology. 1998;2(13):151. (Guideline Ref ID GABRIELIDOU1998)
303.: Gada MT. A comparative study of efficacy on EMG Bio-feedback and progressive muscular relaxation in tension headache. Indian Journal of Psychiatry. 1984;26(2):121–127. (Guideline Ref ID GADA1984) [PMC free article: PMC3012217] [PubMed: 21965970]
304.: Gallagher RM, DeSerio F. Symptomatic treatment for chronic recurring tension headache: a placebo-controlled, multicenter investigation of butalbital 50mg, acetaminophen 325mg, caffeine 40mg, and acetaminophen 325mg, codeine 30mg. International Journal of Clinical Pharmacology and Therapeutics. 1987;41(2):201. [abstract] (Guideline Ref ID GALLAGHER1987)
305.: Gallagher RM, Stagliano RA, Sporazza C. Timolol maleate, a beta blocker, in the treatment of common migraine headache. Headache. 1987;27(2):84–86. (Guideline Ref ID GALLAGHER1987A) [PubMed: 3553070]
306.: Gamzu Elkan PA, Guerard DLA, Scheck F, Peraudeau P, Lacoste JP, Cajfinger F. The Pharmacology of CERETATÍ (CNS1102) and Early Clinical Results: The association of calcium carbasalate-metoclopramide versus dihydroergotamine in the treatment of migraine attacks; 8th-ECNP-(European-College-of-Neuropsychopharmacology)-Congress; Pathologie Biologie; Venice,-Italy. 1995. pp. 806–813. (Guideline Ref ID GAMZUELKAN1995)
307.: Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. The Journal of Headache and Pain. 2011;12(4):475–483. (Guideline Ref ID GAUL2011) [PMC free article: PMC3139052] [PubMed: 21544647]
308.: Gauthier J, Bois R, Allaire D, Drolet M. Evaluation of skin temperature biofeedback training at two different sites for migraine. Journal of Behavioral Medicine. 1981;4(4):407–419. (Guideline Ref ID GAUTHIER1981) [PubMed: 7338895]
309.: Gawel MJ, Worthington I, Maggisano A. A systematic review of the use of triptans in acute migraine. Canadian Journal of Neurological Sciences. 2001;28(1):30–41. (Guideline Ref ID GAWEL2001A) [PubMed: 11252291]
310.: Gelmers HJ. Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine. Headache. 1983;23(3):106–109. (Guideline Ref ID GELMERS1983) [PubMed: 6347970]
311.: Gelmers HJ, Henry P, Lucas J, Holt-Larsen B, Olesen J, Behan P, et al. European multicenter trial of Nimodipine in the prophylaxis of common migraine (migraine without aura). Headache. 1989;29(10):633–638. (Guideline Ref ID GELMERS1989A) [PubMed: 2693405]
312.: Gelmers HJ, Henry P, Lucas J, Holt-Larsen B, Olesen J, Behan P, et al. European multicenter trial of Nimodipine in the prophylaxis of classic migraine (migraine with aura). Headache. 1989;29(10):639–642. (Guideline Ref ID GELMERS1989) [PubMed: 2693406]
313.: Geraud G, Compagnon A, Rossi A. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. Headache: The Journal of Head & Face Pain. 2003;43(3):299–300. (Guideline Ref ID GERAUD2003B) [PubMed: 11844897]
314.: Geraud G, Olesen J, Pfaffenrath V, Tfelt-Hansen P, Zupping R, Diener HC, et al. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Cephalalgia. 2000;20(1):30–38. (Guideline Ref ID GERAUD2000) [PubMed: 10817444]
315.: Gerber WD, Diener HC, Scholz E, Niederberger U. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia. 1991;11(1):37–45. (Guideline Ref ID GERBER1991) [PubMed: 2036669]
316.: Gerber WD, Haag G, Grotemeyer KH, Kropp P, Lindner V, Soyka D, et al. Differential efficacy of ergotamine, paracetamol and ergotamine-paracetamol-combination in the treatment of acute migraine attacks: A multicenter doubleblind study. Cephalalgia. 1991;11(SUPPL 11):174. (Guideline Ref ID GERBER1991A)
317.: Gerber WD, Kropp P, Speckenbach U, Wallasch TM, Winzer O. Central and vascular effects of acetylsalicylic acid (ASA) and ergotamine during migraine attacks: an open randomized study. Functional Neurology Suppl. 1994;9(Suppl 2):25–30. (Guideline Ref ID GERBER1994)
318.: Gerber WD, Miltner W, Birbaumer N. [Behavioral medicine of migraine]. VERHALTENSMEDIZIN DER MIGRANE. Munchener Medizinische Wochenschrift. 1985;127(8):159–162. <ORIGINAL>. (Guideline Ref ID GERBER1985)
319.: Gerber WD, Schellenberg R, Thom M, Haufe C, Bolsche F, Wedekind W, et al. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study. Functional Neurology. 1995;10(1):27–35. (Guideline Ref ID GERBER1995) [PubMed: 7649498]
320.: Gifford AL, Hecht FM. Evaluating HIV-infected patients with headache: who needs computed tomography? Headache. 2001;41(5):441–448. (Guideline Ref ID GIFFORD2001) [PubMed: 11380641]
321.: Gil-Gouveia R, Martins I. Validation of the Portuguese version of ID-Migraine. Headache. 2010;50(3):396–402. (Guideline Ref ID GILGOUVEIA2010) [PubMed: 19473280]
322.: Gilbert MM, De Sola PN, Schecter C. Analgesic/calmative effects of acetaminophen and phenyltoloxamine in treatment of simple nervous tension accompanied by headache. Current Therapeutic Research, Clinical & Experimental. 1976;20(1):53–58. (Guideline Ref ID GILBERT1976) [PubMed: 821705]
323.: Gladstone JP, Dodick DW. Current and emerging treatment options for migraine and other primary headache disorders. Expert Review of Neurotherapeutics. 2003;3(6):845–872. (Guideline Ref ID GLADSTONE2003) [PubMed: 19810888]
324.: Glassman JM, Soyka JP. Muscle contraction (tension) headache: a double-blind study comparing the efficacy and safety of meprobamate-aspirin with butalbital-aspirin-phenacetin-caffeine. Current Therapeutic Research - Clinical and Experimental. 1980;28(6 I):904–915. (Guideline Ref ID GLASSMAN1980)
325.: Glassman JM, Soyka JP, Pollack M. Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982;22(3):101–109. (Guideline Ref ID GLASSMAN1982) [PubMed: 7047460]
326.: Goadsby P. Chronic tension-type headache. Clinical Evidence. 2002;(7):1145–1152. (Guideline Ref ID GOADSBY2002) [PubMed: 12230733]
327.: Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, et al. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee Neurology. 2000;54(1):156–163. (Guideline Ref ID GOADSBY2000) [PubMed: 10636142]
328.: Goadsby PJ, Lipton RB, Ferrari MD. Migraine - Current understanding and treatment. New England Journal of Medicine. 2002;346(4):257–270. (Guideline Ref ID GOADSBY2002A) [PubMed: 11807151]
329.: Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA, et al. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Headache. 1998;38(10):737–747. (Guideline Ref ID GOLDSTEIN1998) [PubMed: 11284462]
330.: Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, et al. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache. 2005;45(8):973–982. (Guideline Ref ID GOLDSTEIN2005) [PubMed: 16109110]
331.: Goldstein J, Silberstein SD, Saper JR, Ryan RE Jr, Lipton RB. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache. 2006;46(3):444–453. (Guideline Ref ID GOLDSTEIN2006) [PubMed: 16618262]
332.: Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. Journal of Neurology, Neurosurgery and Psychiatry. 1973;36(4):684–690. (Guideline Ref ID GOMERSALL1973) [PMC free article: PMC494428] [PubMed: 4731336]
333.: Graf WD, Kayyali HR, Abdelmoity AT, Womelduff GL, Williams AR, Morriss MC. Incidental neuroimaging findings in nonacute headache. Journal of Child Neurology. 2010;25(10):1182–1187. (Guideline Ref ID GRAF2010) [PubMed: 20724750]
334.: Graf WD, Kayyali HR, Alexander JJ, Simon SD, Morriss MC. Neuroimaging-use trends in nonacute pediatric headache before and after clinical practice parameters. Pediatrics. 2008;122(5):e1001–e1005. (Guideline Ref ID GRAF2008) [PubMed: 18838461]
335.: Grahame R. Drug prophylaxis in migraine. A controlled clinical trial. British Medical Journal. 1960;2(5207):1203–1207. (Guideline Ref ID GRAHAME1960) [PMC free article: PMC2096922] [PubMed: 13707746]
336.: Grande RB, Aaseth K, Benth JS, Lundqvist C, Russell MB. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. European Journal of Neurology. 2011;18(1):129–137. (Guideline Ref ID GRANDE2011) [PubMed: 20528911]
337.: Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia. 1987;7(1):15–19. (Guideline Ref ID GRANELLA1987A) [PubMed: 3581158]
338.: Gray CL, Lyle RC, McGuire RJ, Peck DF. Electrode placement, EMG feedback, and relaxation for tension headaches. Behaviour Research & Therapy. 1980;18(1):19–23. (Guideline Ref ID GRAY1980) [PubMed: 7369984]
339.: Grazzi L, Andrasik F, D’Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: Outcome at 3 years. Headache. 2002;42(6):483–490. (Guideline Ref ID GRAZZI2002) [PubMed: 12167136]
340.: Grazzi L, Andrasik F, D’Amico D, Usai S, Kass S, Bussone G. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up. Headache. 2004;44(7):678–683. (Guideline Ref ID GRAZZI2004) [PubMed: 15209690]
341.: Griffith JD, Mycyk MB, Kyriacou DN. Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. Journal of Pain. 2008;9(1):88–94. (Guideline Ref ID GRIFFITH2008) [PubMed: 17981511]
342.: Grimaldi D, Nonino F, Cevoli S, Vandelli A, D’Amico R, Cortelli P. Risk stratification of non-traumatic headache in the emergency department. Journal of Neurology. 2009;256(1):51–57. (Guideline Ref ID GRIMALDI2009) [PubMed: 19221851]
343.: Grosskreutz SR, Osborn RE, Sanchez RM. Computed tomography of the brain in the evaluation of the headache patient. Military Medicine. 1991;156(3):137–140. (Guideline Ref ID GROSSKREUTZ1991) [PubMed: 1901976]
344.: Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. International Journal of Clinical Pharmacology and Therapeutics. 2000;38(9):430–435. (Guideline Ref ID GROSSMANN2000) [PubMed: 11020030]
345.: Gupta A, Rothner AD. Treatment of childhood headaches. Current Neurology & Neuroscience Reports. 2001;1(2):144–154. (Guideline Ref ID GUPTA2001) [PubMed: 11898510]
346.: Haapaniemi H, Hillbom M, Juvela S. Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke; a Journal of Cerebral Circulation. 1997;28(1):26–30. (Guideline Ref ID HAAPANIEMI1997) [PubMed: 8996483]
347.: Haberer LJ, Walls CM, Lener SE, Taylor DR, McDonald SA. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2010;50(3):357–373. (Guideline Ref ID HABERER2010) [PubMed: 20132340]
348.: Hagen K, Albretsen C, Vilming ST, Salvesen R, Gronning M, Helde G, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2009;29(2):221–232. (Guideline Ref ID HAGEN2009) [PubMed: 18823363]
349.: Hagen K, Stovner LJ. A randomized controlled trial on medication-overuse headache: outcome after 1 and 4years. Acta Neurologica Scandinavica Supplementum. 2011;(191):38–43. (Guideline Ref ID HAGEN2011A) [PubMed: 21711255]
350.: Hagen K, Zwart JA, Aamodt AH, Nilsen KB, Brathen G, Helde G, et al. The validity of questionnaire-based diagnoses: the third Nord-Trondelag Health Study 2006–2008. Journal of Headache & Pain. 2010;11(1):67–73. (Guideline Ref ID HAGEN2010A) [PMC free article: PMC3452179] [PubMed: 19946790]
351.: Hagen K, Zwart JA, Vatten L, Stovner LJ, Bovim G. Head-HUNT: validity and reliability of a headache questionnaire in a large population-based study in Norway. Cephalalgia. 2000;20(4):244–251. (Guideline Ref ID HAGEN2000) [PubMed: 10999674]
352.: Hagen K, Albretsen C, Vilming ST, Salvesen R, Gronning M, Helde G, et al. A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. Journal of Headache and Pain. 2011;12(3):315–322. (Guideline Ref ID HAGEN2011) [PMC free article: PMC3094644] [PubMed: 21207237]
353.: Hagen K, Jensen R, Boe MG, Stovner LJ. Medication overuse headache: a critical review of end points in recent follow-up studies. The Journal of Headache and Pain. 2010;11(5):373–377. (Guideline Ref ID HAGEN2010) [PMC free article: PMC3452270] [PubMed: 20473701]
354.: Hakkarainen H, Gustafsson B, Stockman O. A comparative trail of ergotamine tartrate, acetyl salicylic acid and a dextropropoxyphene compound in acute migraine attacks. Headache. 1978;18(1):35–39. (Guideline Ref ID HAKKARAINEN1978) [PubMed: 348645]
355.: Hakkarainen H, Quiding H, Stockman O. Mild analgesics as an alternative to ergotamine in migraine. A comparative trial with acetylsalicylic acid, ergotamine tartrate, and a dextropropoxyphene compound. Journal of Clinical Pharmacology. 1980;20(10):590–595. (Guideline Ref ID HAKKARAINEN1980) [PubMed: 7440766]
356.: Hamalainen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48(1):103–107. (Guideline Ref ID HAMALAINEN1997B) [PubMed: 9008503]
357.: Hanten WP, Olson SL, Hodson JL, Imler VL, Knab VM, Magee JL. The effectiveness of CV-4 and resting position techniques on subjects with tension-type headaches. Journal of Manual & Manipulative Therapy. 1999;7(2):64–70. (Guideline Ref ID HANTEN1999)
358.: Harden RN, Rogers D, Fink K, Gracely RH. Controlled trial of ketorolac in tension-type headache. Neurology. 1998;50(2):507–509. (Guideline Ref ID HARDEN1998) [PubMed: 9484382]
359.: Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. Journal of Adolescent Health. 2002;31(2):154–161. (Guideline Ref ID HAREL2002) [PubMed: 12127385]
360.: Haugh MJ, Lavender L, Jensen LA, Giulano R. An office-based double-blind comparison of dihydroergotamine versus dihydroergotamine/metoclopramide in the treatment of acute migraine. Headache. 1992;32:251. (Guideline Ref ID HAUGH1992)
361.: Havanka H, Dahlof C, Pop PH, Diener HC, Winter P, Whitehouse H, et al. Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Ther. 2000;22(8):970–980. (Guideline Ref ID HAVANKA2000) [PubMed: 10972633]
362.: Havanka-Kanniainen H, Hokkanen E, Myllyla V. Efficacy of nimodipine in comparison with pizotifen (Sandomigrin) in the prophylaxis of migraine. Cephalalgia. 1985;5(Suppl 3):530–531. (Guideline Ref ID HAVANKA1985) [PubMed: 3555838]
363.: Havanka-Kanniainen H, Myllyla VV, Hokkanen E. Nimodipine in the prophylaxis of migraine, a double blind study. Acta Neurologica Scandinavica. 1982;65(Suppl 90):77–78. (Guideline Ref ID HAVANKA1982)
364.: Hayhoe S, Vickers A. Reports on a large, pragmatic, randomised trial: acupuncture for chronic headache in primary care (n=401). Acupuncture in Medicine. 2004;22(2):103–111. (Guideline Ref ID HAYHOE2004)
365.: Health and Public Policy Committee ACoP. Biofeedback for headaches. Annals of Internal Medicine. 1985;102(1):128–131. (Guideline Ref ID HPPC1985) [PubMed: 3881066]
366.: Heathfield KW, Stone P, Crowder D. Pizotifen in the treatment of migraine. Practitioner. 1977;218(1305):428–430. (Guideline Ref ID HEATHFIELD1977) [PubMed: 322111]
367.: Hedborg K, Muhr C. Multimodal behavioral treatment of migraine: an Internet-administered, randomized, controlled trial. Upsala Journal of Medical Sciences. 2011;116(3):169–186. (Guideline Ref ID HEDBORG2011) [PMC free article: PMC3128722] [PubMed: 21506633]
368.: Henderson J. Migraine in women twenty-six to forty-five years of age. Australian Journal of Holistic Nursing. 1999;6(2):10–19. (Guideline Ref ID HENDERSON1999) [PubMed: 11898205]
369.: Henry P, Baille H, Dartigues F, Jogeix M. Headaches and acupuncture. In: Pfaffenrath V, Lundberg PO, Sjaastad O, editors. Updating in headache. Berlin: Springer; 1985. pp. 208–216. (Guideline Ref ID HENRY1985)
370.: Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet. 1991;337(8755):1442–1443. (Guideline Ref ID HERING1991) [PubMed: 1675320]
371.: Hering-Hanit R, Gadoth N, Cohen A, Horev Z. Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. Journal of Child Neurology. 2001;16(6):448–449. (Guideline Ref ID HERINGHANIT2001) [PubMed: 11417614]
372.: Herrmann WM, Horowski R, Dannehl K, Kramer U, Lurati K. Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide. Headache. 1977;17(2):54–60. (Guideline Ref ID HERRMANN1977) [PubMed: 324950]
373.: Hershey AD, Winner P, Kabbouche MA, Gladstein J, Yonker M, Lewis D, et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache. 2005;45(10):1288–1297. (Guideline Ref ID HERSHEY2005) [PubMed: 16324160]
374.: Hesse J, Møgelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation. Journal of Internal Medicine. 1994;235(5):451–456. (Guideline Ref ID HESSE1994) [PubMed: 8182401]
375.: Hilaire ML, Cross LB, Eichner SF. Treatment of migraine headaches with sumatriptan in pregnancy. Annals of Pharmacotherapy. 2004;38(10):1726–1730. (Guideline Ref ID HILAIRE2004) [PubMed: 15316107]
376.: Hobson WH, Shiraki R, Steiner D, Van Horn M. Spinal manipulation vs. amitriptyline for the treatment of chronic tension headache: a randomized clinical trial. Journal of Manipulative and Physiological Therapeutics. 1996;19(4):278–279. (Guideline Ref ID HOBSON1996) [PubMed: 8926482]
377.: Hoffmann W, Herzog B, Muhlig S, Kayser H, Fabian R, Thomsen M, et al. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention. Annals of Pharmacotherapy. 2008;42(12):1804–1813. (Guideline Ref ID HOFFMANN2008) [PubMed: 19001531]
378.: Holmes WF, MacGregor EA, Sawyer JPC, Lipton RB. Information about migraine disability influences physicians’ perceptions of illness severity and treatment needs. Headache. 2001;41(4):343–349. (Guideline Ref ID HOLMES2001) [PubMed: 11318880]
379.: Holroyd KA, Andrasik F, Noble J. A comparison of EMG biofeedback and a credible pseudotherapy in treating tension headache. Journal of Behavioral Medicine. 1980;3(1):29–39. (Guideline Ref ID HOLROYD1980) [PubMed: 6995615]
380.: Holroyd KA, Andrasik F, Westbrook T. Cognitive control of tension headache. Cognitive Therapy and Research. 1977;1(2):121–133. (Guideline Ref ID HOLROYD1977)
381.: Holroyd KA, France JL, Cordingley GE, Rokicki LA, Kvaal SA, Lipchik GL, et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. Journal of Consulting & Clinical Psychology. 1995;63(2):327–330. (Guideline Ref ID HOLROYD1995) [PubMed: 7751496]
382.: Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A. A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive-behavioral) therapies for chronic tension headaches. Journal of Consulting & Clinical Psychology. 1991;59(3):387–393. (Guideline Ref ID HOLROYD1991) [PubMed: 2071723]
383.: Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. Journal of the American Medical Association. 2001;285(17):2208–2215. (Guideline Ref ID HOLROYD2001) [PMC free article: PMC2128735] [PubMed: 11325322]
384.: Holroyd KA, Cottrell CK, O’Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010;341:c4871. (Guideline Ref ID HOLROYD2010) [PMC free article: PMC2947621] [PubMed: 20880898]
385.: Howard L, Wessely S, Leese M, Page L, McCrone P, Husain K, et al. Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache. Journal of Neurology, Neurosurgery and Psychiatry. 2005;76(11):1558–1564. (Guideline Ref ID HOWARD2005) [PMC free article: PMC1739391] [PubMed: 16227551]
386.: Hoyt WH, Shaffer F, Bard DA, Benesler JS, Blankenhorn GD, Gray JH, et al. Osteopathic manipulation in the treatment of muscle-contraction headache. Journal American Osteopathic Association. 1979;78(5):322–325. (Guideline Ref ID HOYT1979) [PubMed: 581588]
387.: Hubbe P. The prophylactic treatment of migraine with an antiserotonin pizotifen. Acta Neurologica Scandinavica. 1973;49(1):108–114. (Guideline Ref ID HUBBE1973) [PubMed: 4567747]
388.: Hudgson P, Foster JB, Newell DJ. Controlled trial of demigran in the prophylaxis of migraine. British Medical Journal. 1967;2(5544):91–93. (Guideline Ref ID HUDGSON1967) [PMC free article: PMC1841258] [PubMed: 6020856]
389.: Hudzinski LG. The significance of muscle discrimination training in the treatment of chronic muscle contraction headache. Headache. 1984;24(4):203–210. (Guideline Ref ID HUDZINSKI1984) [PubMed: 6571404]
390.: Hunton M. A retrospective survey of over 1,000 patients on oral contraceptives in a group practice. Journal of the Royal College of General Practitioners. 1976;26(168):538–546. (Guideline Ref ID HUNTON1976) [PMC free article: PMC2158234] [PubMed: 957317]
391.: Hwang DS, Mietlowski MJ, Friedman AP. Fiorinal with Codeine in the management of tension headache: impact of placebo response. Clinical Therapeutics. 1987;9(2):201–222. (Guideline Ref ID HWANG1987) [PubMed: 3552225]
392.: Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia. 1991;11(2):69–74. (Guideline Ref ID IGARASHI1991) [PubMed: 1860133]
393.: Ilacqua GE. Migraine headaches: coping efficacy of guided imagery training. Headache. 1994;34(2):99–102. (Guideline Ref ID ILACQUA1994) [PubMed: 8163375]
394.: Innes GD, MacPhail I, Dillon EC, Metcalfe C, Gao M. Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM Canadian Journal of Emergency Medical Care. 1999;1(1):26–33. (Guideline Ref ID INNES1999) [PubMed: 17659098]
395.: Jacobs H. A trial of opipramol in the treatment of migraine. Journal of Neurology, Neurosurgery and Psychiatry. 1972;35(4):500–504. (Guideline Ref ID JACOBS1972) [PMC free article: PMC494111] [PubMed: 4559028]
396.: Jammes JL. The treatment of cluster headaches with prednisone. Diseases of the Nervous System. 1975;36(7):375–376. (Guideline Ref ID JAMMES1975) [PubMed: 1097222]
397.: Janssen K, Neutgens J. Autogenic training and progressive relaxation in the treatment of three kinds of headache. Behaviour Research & Therapy. 1986;24(2):199–208. (Guideline Ref ID JANSSEN1986) [PubMed: 3964184]
398.: Jena S, Witt CM, Brinkhaus B, Wegscheider K, Willich SN. Acupuncture in patients with headache. Cephalalgia. 2008;28(9):969–979. (Guideline Ref ID JENA2008) [PubMed: 18624803]
399.: Jensen R, Bendtsen L. Principles and tools: questionnaires, structured interviews, diaries and calendars. In: Olesen J, editor. Classification and diagnosis of headache disorders. Oxford: Oxford University Press; 2005. pp. 20–27. (Guideline Ref ID JENSEN2005)
400.: Jensen R, Tassorelli C, Rossi P, Allena M, Osipova V, Steiner T, et al. A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache. a multicentre European and Latin American study. Cephalalgia. 2011;31(15):1549–1560. (Guideline Ref ID JENSEN2011) [PubMed: 22019575]
401.: John PJ, Sharma N, Sharma CM, Kankane A. Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache. 2007;47(5):654–661. (Guideline Ref ID JOHN2007) [PubMed: 17501846]
402.: Joint Formulary Committee. British National Formulary (BNF). 62nd edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain; 2011. Available from: http://www.bnf.org.uk. (Guideline Ref ID BNF2011)
403.: Joint Formulary Committee. British National Formulary (BNF). 61st edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain; 2011. (Guideline Ref ID BNF2011A)
404.: Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK Jr. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Annals of Emergency Medicine. 1994;24(2):237–241. [Erratum appears in Ann Emerg Med 1994 Oct;24(4):618] (Guideline Ref ID JONES1994) [PubMed: 8037389]
405.: Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011;31(9):1015–1022. (Guideline Ref ID JONSSON2011) [PubMed: 21628444]
406.: Jordan JE, Ramirez GF, Bradley WG, Chen DY, Lightfoote JB, Song A. Economic and outcomes assessment of magnetic resonance imaging in the evaluation of headache. Journal of the National Medical Association. 2000;92(12):573–578. (Guideline Ref ID JORDAN2000) [PMC free article: PMC2568332] [PubMed: 11202760]
407.: Jordan YJ, Lightfoote JB, Jordan JE. Computed tomography imaging in the management of headache in the emergency department: cost efficacy and policy implications. Journal of the National Medical Association. 2009;101(4):331–335. (Guideline Ref ID JORDAN2009) [PubMed: 19397223]
408.: Kagan G, Masheter HC. A controlled study of short-term treatment of tension headache. Current Medical Research & Opinion. 1978;5(9):709–713. (Guideline Ref ID KAGAN1978) [PubMed: 367715]
409.: Kahn CEJ, Sanders GD, Lyons EA, Kostelic JK, MacEwan DW, Gordon WL. Computed tomography for nontraumatic headache: current utilization and cost-effectiveness. Canadian Association of Radiologists Journal. 1993;44(3):189–193. (Guideline Ref ID KAHN1993) [PubMed: 8504331]
410.: Kallela M, Wessman M, Farkkila M. Validation of a migraine-specific questionnaire for use in family studies. European Journal of Neurology. 2001;8(1):61–66. (Guideline Ref ID KALLELA2001) [PubMed: 11509082]
411.: Kallen B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache. 2001;41(4):351–356. (Guideline Ref ID KALLEN2001) [PubMed: 11318881]
412.: Kallen B, Nilsson E, Otterblad Olausson P. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Safety. 2011;34(8):691–703. (Guideline Ref ID KALLEN2011) [PubMed: 21751829]
413.: Kallos P, Kallos-Deffner L. Clinical and experimental evaluation of a new ergot-derivative (ergostine) in the treatment of migraine. Headache. 1971;11(2):68–73. (Guideline Ref ID KALLOS1971) [PubMed: 4938337]
414.: Kang EH, Park JE, Chung CS, Yu BH. Effect of biofeedback-assisted autogenic training on headache activity and mood states in Korean female migraine patients. Journal of Korean Medical Science. 2009;24(5):936–940. (Guideline Ref ID KANG2009) [PMC free article: PMC2752780] [PubMed: 19794995]
415.: Kangasniemi P. Placebo, 1-isopropylnoradrenochrome-5-monosemicarbazono and pizotifen in migraine prophylaxis. Headache. 1979;19(4):219–222. (Guideline Ref ID KANGASNIEMI1979) [PubMed: 156165]
416.: Kangasniemi P, Kaaja R. Ketoprofen and ergotamine in acute migraine. Journal of Internal Medicine. 1992;231(5):551–554. (Guideline Ref ID KANGASNIEMI1992) [PubMed: 1602293]
417.: Kaniecki R, Ruoff G, Smith T, Barrett PS, Ames MH, Byrd S, et al. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache. Current Medical Research and Opinion. 2006;22(8):1535–1544. (Guideline Ref ID KANIECKI2006) [PubMed: 16870078]
418.: Karabetsos A, Karachalios G, Bourlinou P, Reppa A, Koutri R, Fotiadou A. Ketoprofen versus paracetamol in the treatment of acute migraine. Headache. 1997;37(1):12–14. (Guideline Ref ID KARABETSOS1997) [PubMed: 9046717]
419.: Karachalios GN, Fotiadou A, Chrisikos N, Karabetsos A, Kehagioglou K. Treatment of acute migraine attack with diclofenac sodium: a double-blind study. Headache. 1992;32(2):98–100. (Guideline Ref ID KARACHALIOS1992) [PubMed: 1551795]
420.: Karli N, Ertas M, Baykan B, Uzunkaya O, Saip S, Zarifoglu M, et al. The validation of ID Migraine screener in neurology outpatient clinics in Turkey. J Headache Pain. 2007;8(4):217–223. (Guideline Ref ID KARLI2007) [PMC free article: PMC3451667] [PubMed: 17901923]
421.: Karsay K. The relationship between vascular headaches and low-dose oral contraceptives. Therapia Hungarica. 1990;38(4):181–185. (Guideline Ref ID KARSAY1990) [PubMed: 2094059]
422.: Karst M, Reinhard M, Thum P, Wiese B, Rollnik J, Fink M. Needle acupuncture in tension-type headache: a randomized, placebo-controlled study. Cephalalgia. 2001;21(6):637–642. (Guideline Ref ID KARST2001) [PubMed: 11531895]
423.: Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology. 2003;60(10):1682–1683. (Guideline Ref ID KATSARAVA2003) [PubMed: 12771266]
424.: Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005;25(1):12–15. (Guideline Ref ID KATSARAVA2005) [PubMed: 15606564]
425.: Katwere M, Kambugu A, Piloya T, Wong M, Hendel-Paterson B, Sande MA, et al. Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic. Journal of the International AIDS Society. 2009;12(1):21. (Guideline Ref ID KATWERE2009) [PMC free article: PMC2753625] [PubMed: 19765315]
426.: Kaushik R, Kaushik RM, Mahajan SK, Rajesh V. Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine. Complementary Therapies in Medicine. 2005;13(3):165–174. (Guideline Ref ID KAUSHIK2005) [PubMed: 16150370]
427.: Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF, et al. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia. 2000;20(4):233–243. (Guideline Ref ID KELLSTEIN2000) [PubMed: 10999673]
428.: Kelly AM, Ardagh M, Curry C, D’Antonio J, Zebic S. Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine. Journal of Accident & Emergency Medicine. 1997;14(4):209–211. (Guideline Ref ID KELLY1997) [PMC free article: PMC1342939] [PubMed: 9248904]
429.: Kelman L. The broad treatment expectations of migraine patients. Journal of Headache and Pain. 2006;7(6):403–406. (Guideline Ref ID KELMAN2006A) [PMC free article: PMC3452218] [PubMed: 17149569]
430.: Kelman L. Women’s issues of migraine in tertiary care. Headache. 2004;44(1):2–7. (Guideline Ref ID KELMAN2004) [PubMed: 14979877]
431.: Kernick D, Stapley S, Campbell J, Hamilton W. What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2009;29(12):1311–1316. (Guideline Ref ID KERNICK2009) [PubMed: 19911465]
432.: Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2008;28(11):1188–1195. (Guideline Ref ID KERNICK2008A) [PubMed: 18771496]
433.: Kernick D, Stapley S, Hamilton W. GPs’ classification of headache: is primary headache underdiagnosed? British Journal of General Practice. 2008;58(547):102–104. (Guideline Ref ID KERNICK2008B) [PMC free article: PMC2233960] [PubMed: 18307854]
434.: Kewman D, Roberts AH. Skin temperature biofeedback and migraine headaches. A double-blind study. Biofeedback and Self-Regulation. 1980;5(3):327–345. (Guideline Ref ID KEWMAN1980) [PubMed: 7448241]
435.: Khu JV, Siow HC, Ho KH. Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey. Singapore Medical Journal. 2008;49(10):774–779. (Guideline Ref ID KHU2008) [PubMed: 18946609]
436.: Kim ST, Kim CY. Use of the ID Migraine questionnaire for migraine in TMJ and Orofacial Pain Clinic. Headache. 2006;46(2):253–258. (Guideline Ref ID KIM2006) [PubMed: 16492234]
437.: Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998;316(7133):736–741. (Guideline Ref ID KIND1998) [PMC free article: PMC28477] [PubMed: 9529408]
438.: Kinnunen E, Erkinjuntti T, Farkkila M, Palomaki H, Porras J, Teirmaa H, et al. Placebo-controlled double-blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks. Cephalalgia. 1988;8(3):175–179. (Guideline Ref ID KINNUNEN1988) [PubMed: 3143482]
439.: Kirchmann M, Seven E, Bjornsson A, Bjornssdottir G, Gulcher JR, Stefansson K, et al. Validation of the deCODE Migraine Questionnaire (DMQ3) for use in genetic studies. European Journal of Neurology. 2006;13(11):1239–1244. (Guideline Ref ID KIRCHMANN2006) [PubMed: 17038039]
440.: Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia. 1997;17(2):103–108. [Erratum appears in Cephalalgia 1997 Nov;17(7):798] (Guideline Ref ID KLAPPER1997) [PubMed: 9137847]
441.: Klapper J, Stanton J. The emergency treatment of acute migraine headache: A comparison of intravenous dihydroergotamine, dexamethasone, and placebo. Cephalalgia. 1991;11(SUPPL 11):159–160. (Guideline Ref ID KLAPPER1991A)
442.: Klapper JA. Divalproex sodium in migraine prevention. Headache Quarterly. 1996;7(3 SUPPL):16–19. (Guideline Ref ID KLAPPER1996)
443.: Klapper JA, Stanton J. Current emergency treatment of severe migraine headaches. Headache. 1993;33(10):560–562. (Guideline Ref ID KLAPPER1993) [PubMed: 8294195]
444.: Knaus WA, Davis DO. Utilization and cost-effectiveness of cranial computed tomography at a university hospital. Journal of Computer Assisted Tomography. 1978;2(2):209–214. (Guideline Ref ID KNAUS1978) [PubMed: 100533]
445.: Koch GG, Amara IA, MacMillan J. Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headache. Journal of Biopharmaceutical Statistics. 1994;4(3):347–410. (Guideline Ref ID KOCH1994) [PubMed: 7881452]
446.: Kohlenberg RJ, Cahn T. Self-help treatment for migraine headaches: A controlled outcome study. Headache. 1981;21(5):196–200. (Guideline Ref ID KOHLENBERG1981) [PubMed: 7287417]
447.: Koren G, Sharav T, Pastuszak A, Garrettson LK, Hill K, Samson I, et al. A multicenter, prospective study of fetal outcome following accidental carbon monoxide poisoning in pregnancy. Reproductive Toxicology. 1991;5(5):397–403. (Guideline Ref ID KOREN1991) [PubMed: 1806148]
448.: Korkmaz AF. Value of neuroimaging in the evaluation of neurologically normal children with recurrent headache. Journal of Child Neurology. 2002;17(11):807–809. (Guideline Ref ID KORKMAZ2002) [PubMed: 12585718]
449.: Kossoff EH, Mankad DN. Medication-overuse headache in children: is initial preventive therapy necessary? Journal of Child Neurology. 2006;21(1):45–48. (Guideline Ref ID KOSSOFF2006) [PubMed: 16551452]
450.: Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Annals of Emergency Medicine. 2010;56(1):1–6. (Guideline Ref ID KOSTIC2010) [PubMed: 20045576]
451.: Kroener-Herwig B, Denecke H. Cognitive-behavioral therapy of pediatric headache: are there differences in efficacy between a therapist-administered group training and a self-help format? Journal of Psychosomatic Research. 2002;53(6):1107–1114. (Guideline Ref ID KROENERHERWIG2002) [PubMed: 12479993]
452.: Kroner-Herwig B, Fritsche G, Brauer H. The physiological stress response and the role of cognitive coping in migraine patients and non-headache controls. Journal of Psychosomatic Research. 1993;37(5):467–480. (Guideline Ref ID KRONERHERWIG1993) [PubMed: 8350289]
453.: Kroner-Herwig B, Mohn U, Pothmann R. Comparison of biofeedback and relaxation in the treatment of pediatric headache and the influence of parent involvement on outcome. Applied Psychophysiology & Biofeedback. 1998;23(3):143–157. (Guideline Ref ID KRONERHERWIG1998) [PubMed: 10384247]
454.: Krusz JC. Tension-type headaches: what they are and how to treat them. Primary Care; Clinics in Office Practice. 2004;31(2):293–311. [Review] [75 refs] (Guideline Ref ID KRUSZ2004) [PubMed: 15172508]
455.: Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia. 2000;20(2):107–113. (Guideline Ref ID KRYMCHANTOWSKI2000) [PubMed: 10961766]
456.: Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia. 2003;23(10):982–993. (Guideline Ref ID KRYMCHANTOWSKI2003) [PubMed: 14984232]
457.: Krymchantowski AV, da Cunha Jevoux C, Bigal ME. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. Journal of Headache & Pain. 2012;13(1):53–59. (Guideline Ref ID KRYMCHANTOWSKI2012) [PMC free article: PMC3253150] [PubMed: 22008899]
458.: Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache. European Journal of Pain. 2003;7(2):155–162. (Guideline Ref ID KUBITZEK2003) [PubMed: 12600797]
459.: Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache. 1981;21(1):1–4. (Guideline Ref ID KUDROW1981) [PubMed: 7007285]
460.: Kukava M, Dzagnidze A, Janelidze M, Mirvelashvili E, Djibuti M, Fritsche G, et al. Validation of a Georgian language headache questionnaire in a population-based sample. Journal of Headache & Pain. 2007;8(6):321–324. [Erratum appears in J Headache Pain. 2008 Apr;9(2):137 Note: Janelidze, Marina [added]] (Guideline Ref ID KUKAVA2007) [PMC free article: PMC2779392] [PubMed: 18074104]
461.: Labbe EL, Williamson DA. Treatment of childhood migraine using autogenic feedback training. Journal of Consulting & Clinical Psychology. 1984;52(6):968–976. (Guideline Ref ID LABBE1984) [PubMed: 6520289]
462.: Lainez MJ, Castillo J, Dominguez M, Palacios G, Diaz S, Rejas J. New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care. BMC Neurology. 2010;10:39. (Guideline Ref ID LAINEZ2010) [PMC free article: PMC2906427] [PubMed: 20529347]
463.: Lainez MJ, Dominguez M, Rejas J, Palacios G, Arriaza E, Garcia-Garcia M, et al. Development and validation of the Migraine Screen Questionnaire (MS-Q). Headache. 2005;45(10):1328–1338. (Guideline Ref ID LAINEZ2005) [PubMed: 16324165]
464.: Lainez MJ, Galvan J, Heras J, Vila C. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. European Journal of Neurology. 2007;14(3):269–275. (Guideline Ref ID LAINEZ2007A) [PubMed: 17355546]
465.: Lake AE III. Medication overuse headache: Biobehavioral issues and solutions. Headache. 2006;46(SUPPL 3):S88–S97. (Guideline Ref ID LAKEIII2006A) [PubMed: 17034403]
466.: Lance JW, Anthony M. Cyclobenzaprine in the treatment of chronic tension headache. Medical Journal of Australia. 1972;2(25):1409–1411. (Guideline Ref ID LANCE1972) [PubMed: 4568320]
467.: Lance JW, Anthony M, Somerville B. Comparative trial of serotonin antagonists in the management of migraine. British Medical Journal. 1970;2(5705):327–330. (Guideline Ref ID LANCE1970B) [PMC free article: PMC1700164] [PubMed: 4393372]
468.: Lance JW, Fine RD, Curran DA. An evaluation of methysergide in the prevention of migraine and other vascular headaches. Med J Aust. 1963 June;:814–818. (Guideline Ref ID LANCE1963) [PubMed: 13928400]
469.: Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Annals of Emergency Medicine. 1989;18(4):360–365. (Guideline Ref ID LANE1989) [PubMed: 2705667]
470.: Langemark M. Effervescent aspirin in the treatment of tension headache. A double blind, placebo controlled cross-over study. Cephalalgia. 1985;5(Suppl 3):152–153. (Guideline Ref ID LANGEMARK1985)
471.: Langemark M, Loldrup D, Bech P, Olesen J. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache. 1990;30(3):118–121. (Guideline Ref ID LANGEMARK1990) [PubMed: 2182566]
472.: Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study. Headache. 1987;27(2):90–95. (Guideline Ref ID LANGEMARK1987) [PubMed: 3553071]
473.: Larkin GL, Prescott JE. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Annals of Emergency Medicine. 1992;21(8):919–924. (Guideline Ref ID LARKIN1992) [PubMed: 1497157]
474.: Larson EB. Diagnostic evaluation of headache. Impact of computerized tomography and cost-effectiveness. Journal of the American Medical Association. 1980;243(4):359–362. (Guideline Ref ID LARSON1980) [PubMed: 6766193]
475.: Larsson B, Carlsson J. A school-based, nurse-administered relaxation training for children with chronic tension-type headache. Journal of Pediatric Psychology. 1996;21(5):603–614. (Guideline Ref ID LARSSON1996) [PubMed: 8936891]
476.: Larsson B, Daleflod B, Hakansson L, Melin L. Therapist-assisted versus self-help relaxation treatment of chronic headaches in adolescents: a school-based intervention. Journal of Child Psychology & Psychiatry & Allied Disciplines. 1987;28(1):127–136. (Guideline Ref ID LARSSON1987) [PubMed: 3104371]
477.: Larsson B, Melin L. Chronic headaches in adolescents: treatment in a school setting with relaxation training as compared with information-contact and self-registration. Pain. 1986;25(3):325–336. (Guideline Ref ID LARSSON1986) [PubMed: 3528989]
478.: Latsko M, Silberstein S, Rosen N. Frovatriptan as preemptive treatment for fasting-induced migraine. Headache. 2011;51(3):369–374. (Guideline Ref ID LATSKO2011) [PubMed: 21269298]
479.: Laurell K, Larsson B, Eeg-Olofsson O. Headache in schoolchildren: agreement between different sources of information. Cephalalgia. 2003;23(6):420–428. (Guideline Ref ID LAURELL2003) [PubMed: 12807521]
480.: Laveneziana D, Speranza R, Raulli P, Paredi G. Comparative efficacy of ibuprofen arginine and beta-cyclodextrin piroxicam as treatment for tension-type headache. Clinical Drug Investigation. 1996;11(SUPPL 1):22–26. (Guideline Ref ID LAVENEZIANA1996)
481.: Lavies NG. Laser acupuncture for migraine and muscle tension headache: a double-blind controlled trial. Acupuncture in Medicine. 1998;16(2):73–76. (Guideline Ref ID LAVIES1998)
482.: Lawler SP, Cameron LD. A randomized, controlled trial of massage therapy as a treatment for migraine. Annals of Behavioral Medicine. 2006;32(1):50–59. (Guideline Ref ID LAWLER2006) [PubMed: 16827629]
483.: Lawrence ER, Hossain M, Littlestone W. Sanomigran for migraine prophylaxis, controlled multicenter trial in general practice. Headache. 1977;17(3):109–112. (Guideline Ref ID LAWRENCE1977) [PubMed: 330465]
484.: Le Jeunne C, Gomez JP, Pradalier A, Albareda F, Joffroy A, Liano H, et al. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks. European Neurology. 1999;41(1):37–43. (Guideline Ref ID LEJEUNE1999) [PubMed: 9885327]
485.: Lea R, Colson N, Quinlan S, MacMillan J, Griffiths L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenetics and Genomics. 2009;19(6):422–428. (Guideline Ref ID LEA2009) [PubMed: 19384265]
486.: Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache. 2002;42(9):845–854. (Guideline Ref ID LEMSTRA2002) [PubMed: 12390609]
487.: Leone M, D’Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology. 2000;54(6):1382–1385. (Guideline Ref ID LEONE2000) [PubMed: 10746617]
488.: Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia. 1996;16(7):494–496. (Guideline Ref ID LEONE1996) [PubMed: 8933994]
489.: Lewis DW, Dorbad D. The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations. Headache. 2000;40(8):629–632. (Guideline Ref ID LEWIS2000) [PubMed: 10971658]
490.: Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics. 2009;123(3):924–934. (Guideline Ref ID LEWIS2009) [PubMed: 19255022]
491.: Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, et al. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiology Biomarkers and Prevention. 2009;18(7):2030–2034. (Guideline Ref ID LI2009A) [PMC free article: PMC2756173] [PubMed: 19589913]
492.: Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22(1):66–69. (Guideline Ref ID LI2002) [PubMed: 11993616]
493.: Li Y, Liang F, Yang X, Tian X, Yan J, Sun G, et al. Acupuncture for treating acute attacks of migraine: a randomized controlled trial. Headache. 2009;49(6):805–816. (Guideline Ref ID LI2009) [PubMed: 19438740]
494.: Li Y, Zheng H, Witt CM, Roll S, Yu Sg, Yan J, et al. Acupuncture for migraine prophylaxis: a randomized controlled trial. Canadian Medical Association Journal. 2012. (Guideline Ref ID LI2012) [PMC free article: PMC3291669] [PubMed: 22231691]
495.: Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. British Journal of Obstetrics and Gynaecology. 1995;102(2):153–159. (Guideline Ref ID LIDEGAARD1995) [PubMed: 7756208]
496.: Lidegaard O, Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception. 2002;65(3):197–205. (Guideline Ref ID LIDEGAARD2002) [PubMed: 11929641]
497.: Limmroth V, May A, Diener H. Lysine-acetylsalicylic acid in acute migraine attacks. European Neurology. 1999;41(2):88–93. (Guideline Ref ID LIMMROTH1999) [PubMed: 10023111]
498.: Limmroth V, Biondi D, Pfeil J, Schwalen S. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Headache. 2007;47(1):13–21. (Guideline Ref ID LIMMROTH2007) [PubMed: 17355489]
499.: Linde K, Streng A, Hoppe A, Brinkhaus B, Witt C, Hammes M, et al. Treatment in a Randomized Multicenter Trial of Acupuncture for Migraine (ART Migraine). Forschende Komplementarmedizin Und Klassische Naturheilkunde. 2006;13(2):101–108. (Guideline Ref ID LINDE2006A) [PubMed: 16645290]
500.: Linde K, Streng A, Hoppe A, Weidenhammer W, Wagenpfeil S, Melchart D. Randomized trial vs. observational study of acupuncture for migraine found that patient characteristics differed but outcomes were similar. Journal of Clinical Epidemiology. 2007;60(3):280–287. (Guideline Ref ID LINDE2007) [PubMed: 17292022]
501.: Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, et al. Acupuncture for patients with migraine: a randomized controlled trial. Journal of the American Medical Association. 2005;293(17):2118–2125. (Guideline Ref ID LINDE2005) [PubMed: 15870415]
502.: Linton-Dahlof P, Linde M, Dahlof C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia. 2000;20(7):658–662. (Guideline Ref ID LINTONDAHLOF2000) [PubMed: 11128824]
503.: Lipton R, Cady R, Stewart W, Wilks K, Hall C. Diagnostic lessons from the spectrum study. Headache. 2003;43(4):423. (Guideline Ref ID LIPTON2003A)
504.: Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med. 2000;160(22):3486–3492. (Guideline Ref ID LIPTON2000) [PubMed: 11112243]
505.: Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61(3):375–382. (Guideline Ref ID LIPTON2003B) [PubMed: 12913201]
506.: Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240–2244. (Guideline Ref ID LIPTON2004) [PubMed: 15623680]
507.: Lipton RB, Stewart WF, Cady R, Hall C, O’Quinn S, Kuhn T, et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000;40(10):783–791. (Guideline Ref ID LIPTON2000A) [PubMed: 11135021]
508.: Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches: A comparison of symptom-based and reported physician diagnosis. Archives of Internal Medicine. 1992;152(6):1273–1278. (Guideline Ref ID LIPTON1992) [PubMed: 1599358]
509.: Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, et al. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study. Cephalalgia. 2011;31(1):18–30. (Guideline Ref ID LIPTON2011) [PubMed: 20974598]
510.: Locker T, Mason S, Rigby A. Headache management--are we doing enough? An observational study of patients presenting with headache to the emergency department. Emergency Medicine Journal. 2004;21(3):327–332. (Guideline Ref ID LOCKER2004) [PMC free article: PMC1726346] [PubMed: 15107372]
511.: Locker TE, Thompson C, Rylance J, Mason SM. The utility of clinical features in patients presenting with nontraumatic headache: an investigation of adult patients attending an emergency department. Headache. 2006;46(6):954–961. (Guideline Ref ID LOCKER2006) [PubMed: 16732841]
512.: Loder E. Cluster headache from the patient’s point of view. Current Pain and Headache Reports. 2005;9(2):120–125. (Guideline Ref ID LODER2005) [PubMed: 15745622]
513.: Loder E. Safety of sumatriptan in pregnancy: a review of the data so far. CNS Drugs. 2003;17(1):1–7. (Guideline Ref ID LODER2003) [PubMed: 12467489]
514.: Loew TH, Sohn R, Martus P, Tritt K, Rechlin T. Functional relaxation as a somatopsychotherapeutic intervention: a prospective controlled study. Alternative Therapies in Health & Medicine. 2000;6(6):70–75. (Guideline Ref ID LOEW2000) [PubMed: 11076449]
515.: Lofland JH, Kim SS, Batenhorst AS, Johnson NE, Chatterton ML, Cady RK, et al. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine. Mayo Clinic Proceedings. 2001;76(11):1093–1101. (Guideline Ref ID LOFLAND2001) [PubMed: 11702897]
516.: Loh L, Nathan PW, Schott GD, Zilkha KJ. Acupuncture versus medical treatment for migraine and muscle tension headaches. Journal of Neurology, Neurosurgery and Psychiatry. 1984;47(4):333–337. (Guideline Ref ID LOH1984) [PMC free article: PMC1027772] [PubMed: 6726258]
517.: Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974;50(1):109–115. (Guideline Ref ID LUDVIGSSON1974) [PubMed: 4839065]
518.: Lujan M, Lopez-Fiesco A, Martinez E, Zamora LG, Alvarez RM. Experimental tension headache in humans: a double blind comparison of the analgesic effect of dipyrone, naproxen plus paracetamol or placebo. Proceedings of the Western Pharmacology Society. 1992;35:201–205. (Guideline Ref ID LUJAN1992) [PubMed: 1502224]
519.: MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke; a Journal of Cerebral Circulation. 2007;38(9):2438–2445. (Guideline Ref ID MACCLELLAN2007) [PubMed: 17690308]
520.: Machado RB, Pereira AP, Coelho GP, Neri L, Martins L, Luminoso D. Epidemiological and clinical aspects of migraine in users of combined oral contraceptives. Contraception. 2010;81(3):202–208. (Guideline Ref ID MACHADO2010) [PubMed: 20159175]
521.: Mack KJ. What incites new daily persistent headache in children? Pediatric Neurology. 2004;31(2):122–125. (Guideline Ref ID MACK2004) [PubMed: 15301832]
522.: MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. Journal of Child Neurology. 2008;23(11):1300–1304. (Guideline Ref ID MACLENNAN2008) [PubMed: 18984840]
523.: Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, et al. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study. American Journal of Obstetrics and Gynecology. 1996;174(3):823–828. (Guideline Ref ID MAGEE1996) [PubMed: 8633650]
524.: Maizels M, Burchette R. Rapid and sensitive paradigm for screening patients with headache in primary care settings. Headache. 2003;43(5):441–450. (Guideline Ref ID MAIZELS2003A) [PubMed: 12752748]
525.: Malvea BP, Gwon N, Graham JR. Propranolol prophylaxis of migraine. Headache. 1973;12(4):163–167. (Guideline Ref ID MALVEA1973) [PubMed: 4566216]
526.: Mannix LK, Chandurkar RS, Rybicki LA, Tusek DL, Solomon GD. Effect of guided imagery on quality of life for patients with chronic tension-type headache. Headache. 1999;39(5):326–334. (Guideline Ref ID MANNIX1999A) [PubMed: 11279912]
527.: Mansoureh T, Rahmat Jirde M, Nilavari K, Ashrafian H, Razeghi S, Kohan L. Cinnarizine in refractory migraine prophylaxis: Efficacy and tolerability. A comparison with sodium valproate. Journal of Headache and Pain. 2008;9(2):77–82. (Guideline Ref ID MANSOUREH2008) [PMC free article: PMC3476188] [PubMed: 18286231]
528.: Manzano S, Doyon-Trottier E, Bailey B. Myth: Ibuprofen is superior to acetaminophen for the treatment of benign headaches in children and adults. CJEM Canadian Journal of Emergency Medical Care. 2010;12(3):220–222. (Guideline Ref ID MANZANO2010) [PubMed: 20522287]
529.: Marcus DA, Bernstein CD, Sullivan EA, Rudy TE. A prospective comparison between ICHD-II and probability menstrual migraine diagnostic criteria. Headache. 2010;50(4):539–550. (Guideline Ref ID MARCUS2010) [PubMed: 20236338]
530.: Marcus DA, Kapelewski C, Jacob RG, Rudy TE, Furman JM. Validation of a brief nurse-administered migraine assessment tool. Headache. 2004;44(4):328–332. (Guideline Ref ID MARCUS2004) [PubMed: 15109357]
531.: Martin PR, Nathan PR, Milech D, van Keppel M. Cognitive therapy vs. self-management training in the treatment of chronic headaches. British Journal of Clinical Psychology. 1989;28(Pt 4):347–361. (Guideline Ref ID MARTIN1989) [PubMed: 2605388]
532.: Martin R. What Europeans are doing to limit migraine frequency. Life Extension. 2006;12(3):30–36. (Guideline Ref ID MARTIN2006)
533.: Martin VT. Medication overuse and chronic migraine. Current Pain and Headache Reports. 2009;13(5):337–339. (Guideline Ref ID MARTIN2009) [PubMed: 19728958]
534.: Martinez HR, Londono O, Cantu-Martinez L, Tarin LDC, Castillo CD. Topiramate as an Adjunctive Treatment in Migraine Prophylaxis. Headache. 2003;43(10):1080–1084. (Guideline Ref ID MARTINEZ2003) [PubMed: 14629243]
535.: Massiou H. A comparison os sumatriptan nasal spray and intranasal dhiydroergotamine (DHE) in the acute treatment of migraine. Functional Neurology. 1996;2/3(11):151. (Guideline Ref ID MASSIOU1996)
536.: Matchar DB, Harpole L, Samsa GP, Jurgelski A, Lipton RB, Silberstein SD, et al. The headache management trial: a randomized study of coordinated care. Headache. 2008;48(9):1294–1310. (Guideline Ref ID MATCHAR2008) [PubMed: 18547268]
537.: Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Annals of Neurology. 2004;56(4):488–494. (Guideline Ref ID MATHARU2004) [PubMed: 15455406]
538.: Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache. 1981;21(3):105–109. (Guideline Ref ID MATHEW1981) [PubMed: 7021472]
539.: Mathew NT, Hulihan JF, Rothrock JF. Anticonvulsants in migraine prophylaxis. Neurology. 2003;60(7 SUPPL 2):S45–S49. (Guideline Ref ID MATHEW2003)
540.: Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001;41(2):119–128. (Guideline Ref ID MATHEW2001B) [PubMed: 11251695]
541.: Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, et al. Migraine prophylaxis with divalproex. Archives of Neurology. 1995;52(3):281–286. (Guideline Ref ID MATHEW1995) [PubMed: 7872882]
542.: Mauskop A, Altura BM. Magnesium for migraine: Rationale for use and therapeutic potential. CNS Drugs. 1998;9(3):185–190. (Guideline Ref ID MAUSKOP1998A)
543.: Maytal J, Bienkowski RS, Patel M, Eviatar L. The value of brain imaging in children with headaches. Pediatrics. 1995;96(3 Pt 1):413–416. (Guideline Ref ID MAYTAL1995) [PubMed: 7651770]
544.: McGrady A, Wauquier A, McNeil A, Gerard G. Effect of biofeedback-assisted relaxation on migraine headache and changes in cerebral blood flow velocity in the middle cerebral artery. Headache. 1994;34(7):424–428. (Guideline Ref ID MCGRADY1994) [PubMed: 7928327]
545.: McGrath PJ, Humphreys P, Goodman JT, Keene D, Firestone P, Jacob P, et al. Relaxation prophylaxis for childhood migraine: a randomized placebo-controlled trial. Developmental Medicine & Child Neurology. 1988;30(5):626–631. (Guideline Ref ID MCGRATH1988) [PubMed: 3229560]
546.: Medical Advisory Secretariat. Neuroimaging for the evaluation of chronic headaches: an evidence-based analysis. 2010. Available from: http://www.health.gov.on.ca/english/providers/program/ohtac/tech/draft_comment/rev_neuro_20100714.pdf. (Guideline Ref ID MEDICAL2010A) [PMC free article: PMC3377587] [PubMed: 23074404]
547.: Medina JL, Fareed J, Diamond S. Lithium carbonate therapy for cluster headache. Changes in number of platelets, and serotonin and histamine levels. Archives of Neurology. 1980;37(9):559–563. (Guideline Ref ID MEDINA1980) [PubMed: 7417056]
548.: Medina LS, Pinter JD, Zurakowski D, Davis RG, Kuban K, Barnes PD. Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology. 1997;202(3):819–824. (Guideline Ref ID MEDINA1997) [PubMed: 9051039]
549.: Mehlisch DR, Weaver M, Fladung B. Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache. 1998;38(8):579–589. (Guideline Ref ID MEHLISCH1998) [PubMed: 11398300]
550.: Mehvari J, Rafieian-Kopaei M. Prophylactic activity of cyproheptadine and Bellergal on migraine headache. Iranian Journal of Medical Sciences. 2005;30(2):84–87. (Guideline Ref ID MEHVARI2005)
551.: Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, et al. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Neurological Sciences. 2004;25(5):245–250. (Guideline Ref ID MEI2004) [PubMed: 15624081]
552.: Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, et al. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clinical Neuropharmacology. 2006;29(5):269–275. (Guideline Ref ID MEI2006) [PubMed: 16960472]
553.: Melchart D, Streng A, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, et al. Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ (Clinical Research Ed). 2005;331(7513):376–382. (Guideline Ref ID MELCHART2005) [PMC free article: PMC1184247] [PubMed: 16055451]
554.: Melchart D, Streng A, Hoppe A, Linde K, Brinkhaus B, Becker-Witt C, et al. The acupuncture randomised trial (ART) for tension-type headache - Details of the treatment. Acupuncture in Medicine. 2005;23(4):157–165. (Guideline Ref ID MELCHART2005A) [PubMed: 16430123]
555.: Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. Journal of Internal Medicine. 2003;253(2):181–188. (Guideline Ref ID MELCHART2003B) [PubMed: 12542558]
556.: Metsahonkala L, Sillanpaa M, Tuominen J. Headache diary in the diagnosis of childhood migraine. Headache. 1997;37(4):240–244. (Guideline Ref ID METSAHONKALA1997) [PubMed: 9150620]
557.: Meyer GA. The art of watching out: vigilance in women who have migraine headaches. Qualitative Health Research. 2002;12(9):1220–1234. (Guideline Ref ID MEYER2002) [PubMed: 12448668]
558.: Meyer JS, Hardenberg J. Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache. 1983;23(6):266–277. (Guideline Ref ID MEYER1983) [PubMed: 6358126]
559.: Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clinical Pharmacology & Therapeutics. 1994;56(5):576–586. (Guideline Ref ID MIGLIARDI1994) [PubMed: 7955822]
560.: Miller DS, Talbot CA, Simpson W, Korey A. A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache. 1987;27(7):392–396. (Guideline Ref ID MILLER1987) [PubMed: 3308770]
561.: Misra UK, Jose M, Kalita J. Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial. Postgrad Med J. 2004;80(950):720–723. (Guideline Ref ID MISRA2004) [PMC free article: PMC1743152] [PubMed: 15579612]
562.: Misra UK, Kalita J, Yadav RK. Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial. J Headache Pain. 2007;8(3):175–179. (Guideline Ref ID MISRA2007) [PMC free article: PMC3476139] [PubMed: 17563841]
563.: Mitchell CS, Osborn RE, Grosskreutz SR. Computed tomography in the headache patient: is routine evaluation really necessary? Headache. 1993;33(2):82–86. (Guideline Ref ID MITCHELL1993) [PubMed: 8458727]
564.: Mitsikostas DD, Mantonakis LI, Chalarakis NG. Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia. 2011;31(5):550–561. (Guideline Ref ID MITSIKOSTAS2011) [PubMed: 21216874]
565.: Moloney MF, Aycock DM, Cotsonis GA, Myerburg S, Farino C, Lentz M. An Internet-based migraine headache diary: issues in Internet-based research. Headache. 2009;49(5):673–686. (Guideline Ref ID MOLONEY2009) [PubMed: 19472446]
566.: Moloney MF, Strickland OL, De Rossett SE, Melby MK, Dietrich AS. The experiences of midlife women with migraines. Journal of Nursing Scholarship. 2006;38(3):278–285. (Guideline Ref ID MOLONEY2006) [PubMed: 17044346]
567.: Mongini F, Ciccone G, Rota E, Ferrero L, Ugolini A, Evangelista A, et al. Effectiveness of an educational and physical programme in reducing headache, neck and shoulder pain: a workplace controlled trial. Cephalalgia. 2008;28(5):541–552. (Guideline Ref ID MONGINI2008) [PubMed: 18318746]
568.: Mongini F, Evangelista A, Rota E, Ferrero L, Ugolini A, Ceccarelli M, et al. Long-term benefits of an educational and physical program on headache, and neck and shoulder pain, in a working community. Journal of Pain. 2009;10(11):1138–1145. (Guideline Ref ID MONGINI2009) [PubMed: 19398381]
569.: Mongini F, Evangelista A, Rota E, Ferrero L, Ugolini A, Milani C, et al. Further evidence of the positive effects of an educational and physical program on headache, neck and shoulder pain in a working community. Journal of Headache and Pain. 2010;11(5):409–415. (Guideline Ref ID MONGINI2010) [PMC free article: PMC3452277] [PubMed: 20563879]
570.: Monstad I, Krabbe A, Micieli G, Prusinski A, Cole J, Pilgrim A, et al. Preemptive oral treatment with sumatriptan during a cluster period. Headache. 1995;35(10):607–613. (Guideline Ref ID MONSTAD1995) [PubMed: 8550362]
571.: Monteith TS, Sprenger T. Tension type headache in adolescence and childhood: Where are we now? Current Pain and Headache Reports. 2010;14(6):424–430. (Guideline Ref ID MONTEITH2010) [PMC free article: PMC2964486] [PubMed: 20927610]
572.: Moore KL, Leone M, D’Amico D, Frediani F, Moschiano P, Grazzi L, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Headache: The Journal of Head & Face Pain. 2001;41(3):330. (Guideline Ref ID MOORE2001)
573.: Moran R. Effectiveness of cervical spine manipulation and prescribed exercise in reduction of cervicogenic headache pain and frequency: A single case study experimental design. International Journal of Osteopathic Medicine. 2005;8(3):114–116. (Guideline Ref ID MORAN2005)
574.: Mostardini C, d’Agostino VC, Dugoni DE, Cerbo R. A possible role of ID-Migraine in the emergency department: study of an emergency department out-patient population. Cephalalgia. 2009;29(12):1326–1330. (Guideline Ref ID MOSTARDINI2009) [PubMed: 19438919]
575.: Munksgaard SB, Allena M, Tassorelli C, Rossi P, Katsarava Z, Bendtsen L, et al. What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? Journal of Headache and Pain. 2011;12(1):91–96. (Guideline Ref ID MUNKSGAARD2011) [PMC free article: PMC3055992] [PubMed: 21336966]
576.: Myers DE, Myers RA. A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache. 1995;35(4):197–199. (Guideline Ref ID MYERS1995) [PubMed: 7775175]
577.: Myllyla VV, Havanka H, Herrala L, Kangasniemi P, Rautakorpi I, Turkka J, et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache. 1998;38(3):201–207. (Guideline Ref ID MYLLYLA1998) [PubMed: 9563211]
578.: Nair KG. A pilot study of the value of propranolol in migraine. Journal of Postgraduate Medicine. 1975;21(3):111–113. (Guideline Ref ID NAIR1975) [PubMed: 1107526]
579.: Nanda RN, Johnson RH, Gray J, Keogh HJ, Melville ID. A double blind trial of acebutolol for migraine prophylaxis. Headache. 1978;18(1):20–22. (Guideline Ref ID NANDA1978) [PubMed: 348644]
580.: Nappi G, Jensen R, Nappi RE, Sances G, Torelli P, Olesen J. Diaries and calendars for migraine. A review. Cephalalgia. 2006;26(8):905–916. (Guideline Ref ID NAPPI2006) [PubMed: 16886925]
581.: Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol. 1994;241(3):138–144. (Guideline Ref ID NAPPI1994) [PubMed: 8164015]
582.: National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2009. Available from: http://www.nice.org.uk/aboutnice/howwework/developingniceclinicalguidelines/clinicalguidelinedevelopmentmethods/GuidelinesManual2009.jsp. (Guideline Ref ID NICE2009) [PubMed: 27905714]
583.: Nattero G, Biale L, Savi L. Lisuride and pizotifen in the treatment of migraine without aura. Cephalalgia. 1991:218–219. (Guideline Ref ID NATTERO1991)
584.: Nebe J, Heier M, Diener HC. Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia. 1995;15(6):531–535. (Guideline Ref ID NEBE1995) [PubMed: 8706118]
585.: Nelles G, Schmitt L, Humbert T, Becker V, Sandow P, Bornhoevd K, et al. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting. Journal of Headache & Pain. 2010;11(1):33–44. (Guideline Ref ID NELLES2010) [PMC free article: PMC3452185] [PubMed: 19894100]
586.: Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache. Journal of Manipulative and Physiological Therapeutics. 1998;21(8):511–519. (Guideline Ref ID NELSON1998A) [PubMed: 9798179]
587.: Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache. 2001;41(3):248–256. (Guideline Ref ID NEWMAN2001) [PubMed: 11264684]
588.: Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache. 2010;50(4):563–575. (Guideline Ref ID NEZVALOVA2010) [PubMed: 20132339]
589.: Nicolodi M, Del Bianco PL, Sicuteri F. The way to serotonergic use and abuse in migraine. International Journal of Clinical Pharmacology Research. 1997;17(2–3):79–84. (Guideline Ref ID NICOLODI1997) [PubMed: 9403359]
590.: Nielsen KD, Rasmussen C, Russell MB. The diagnostic headache diary--a headache expert system. Studies in Health Technology & Informatics. 2000;78:149–160. (Guideline Ref ID NIELSEN2000) [PubMed: 11151594]
591.: Niere K, Jerak A. Measurement of headache frequency, intensity and duration: comparison of patient report by questionnaire and headache diary. Physiotherapy Research International. 2004;9(4):149–156. (Guideline Ref ID NIERE2004) [PubMed: 15790252]
592.: Nightingale AL, Farmer RDT. Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database. Stroke; a Journal of Cerebral Circulation. 2004;35(7):1574–1578. (Guideline Ref ID NIGHTINGALE2004) [PubMed: 15143296]
593.: Nilsson Remahl AI, Ansjon R, Lind F, Waldenlind E. Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study. Cephalalgia. 2002;22(9):730–739. (Guideline Ref ID NILSSONREMAHL2002) [PubMed: 12421159]
594.: Noone JF. Clomipramine in the prevention of migraine. Journal of International Medical Research. 1980;8 Suppl 3:49–52. (Guideline Ref ID NOONE1980) [PubMed: 7009254]
595.: Obermann M, Katsarava Z. Management of medication-overuse headache. Expert Review of Neurotherapeutics. 2007;7(9):1145–1155. (Guideline Ref ID OBERMANN2007) [PubMed: 17868013]
596.: Oguzhanoglu A, Sahiner T, Kurt T, Akalin O. Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches. Cephalalgia. 1999;19(5):531–532. (Guideline Ref ID OGUZHANOGLU1999) [PubMed: 10403070]
597.: Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. Pregnancy outcome following prescription for sumatriptan. Headache. 2000;40(1):20–24. (Guideline Ref ID OLESEN2000) [PubMed: 10759898]
598.: Orholm M, Honore PF, Zeeberg I. A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine. Acta Neurologica Scandinavica. 1986;74(3):235–239. (Guideline Ref ID ORHOLM1986) [PubMed: 3538753]
599.: Osborn RE, Alder DC, Mitchell CS. MR imaging of the brain in patients with migraine headaches. American Journal of Neuroradiology. 1991;12(3):521–524. (Guideline Ref ID OSBORN1991) [PMC free article: PMC8333013] [PubMed: 2058506]
600.: Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005;45(2):144–152. (Guideline Ref ID OZYALCIN2005) [PubMed: 15705120]
601.: Packard RC. What does the headache patient want? Headache. 1979;19(7):370–374. (Guideline Ref ID PACKARD1979) [PubMed: 511538]
602.: Packman B, Packman E, Doyle G, Cooper S, Ashraf E, Koronkiewicz K, et al. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache. 2000;40(7):561–567. (Guideline Ref ID PACKMAN2000) [PubMed: 10940094]
603.: Padma MV, Jain S, Maheshwari MC, Misra S, Karak B, Singh AK. Efficacy and tolerability of oral sumatriptan in Indian patients with acute migrane: a multicentre study. Neurology India. 1998;46(2):105–108. (Guideline Ref ID PADMA1998) [PubMed: 29508796]
604.: Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology. 2006;67(1):109–113. (Guideline Ref ID PAEMELEIRE2006) [PubMed: 16832088]
605.: Pageler L, Katsarava Z, Diener HC, Limmroth V. Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia. 2008;28(2):152–156. (Guideline Ref ID PAGELER2008) [PubMed: 18039339]
606.: Pageler L, Katsarava Z, Lampl C, Straube A, Evers S, Diener HC, et al. Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache. 2011;51(1):129–134. (Guideline Ref ID PAGELER2011) [PubMed: 21198573]
607.: Pageler L, Savidou I, Limmroth V. Medication-overuse headache. Current Pain and Headache Reports. 2005;9(6):430–435. (Guideline Ref ID PAGELER2005) [PubMed: 16282044]
608.: Palferman TG, Gibberd FB, Simmonds JP. Prophylactic propranolol in the treatment of headache. British Journal of Clinical Practice. 1983;37(1):28–29. (Guideline Ref ID PALFERMAN1983) [PubMed: 6340710]
609.: Parker GB, Tupling H, Pryor DS. A controlled trial of cervical manipulation for migraine. Aust N Z J Med. 1978;8(6):589–593. (Guideline Ref ID PARKER1978) [PubMed: 373735]
610.: Passchier J, van den Bree MB, Emmen HH, Osterhaus SO, Orlebeke JF, Verhage F. Relaxation training in school classes does not reduce headache complaints. Headache. 1990;30(10):660–664. (Guideline Ref ID PASSCHIER1990) [PubMed: 2272818]
611.: Paterna S, Di PP, Arrostuto SMA, Ingurgio NC, Gullotti GPD, Licata G. Captopril versus placebo for prophylaxis of migraine without aura. A double-blind randomized study. Clin Ter. 1992;141(12):475–481. (Guideline Ref ID PATERNA1992) [PubMed: 1493669]
612.: Patten JP. Clinical experience with oral sumatriptan: a placebo-controlled, dose-ranging study. Oral Sumatriptan Dose-defining Study Group. J Neurol. 1991;238 Suppl 1:S62–S65. (Guideline Ref ID PATTEN1991) [PubMed: 1646290]
613.: Payne K, Kozma CM, Lawrence BJ. Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine: a retrospective cost-efficacy analysis. Pharmacoeconomics. 1996;10(1):59–71. (Guideline Ref ID PAYNE1996) [PubMed: 10160470]
614.: Pearce I, Frank GJ, Pearce JM. Ibuprofen compared with paracetamol in migraine. Practitioner. 1983;227(1377):465–467. (Guideline Ref ID PEARCE1983) [PubMed: 6351046]
615.: Peatfield RC, Petty RG, Rose FC. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia. 1983;3(2):129–134. (Guideline Ref ID PEATFIELD1983) [PubMed: 6347393]
616.: Pedersen E, Moller CE. Methysergide in migraine prophylaxis. Clinical Pharmacology & Therapeutics. 1966;7(4):520–526. (Guideline Ref ID PEDERSEN1966) [PubMed: 5328472]
617.: Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257–263. (Guideline Ref ID PEIKERT1996) [PubMed: 8792038]
618.: Pengiran Tengah DS, Byrne PO, Wills AJ. Urgent 2-week referrals for CNS/brain tumours: a retrospective audit. Clinical Oncology (Royal College of Radiologists). 2003;15(1):7–9. (Guideline Ref ID PENGIRANTENGAH2003) [PubMed: 12602547]
619.: Peters BH, Fraim CJ, Masel BE. Comparison of 650 mg aspirin and 1,000 mg acetaminophen with each other, and with placebo in moderately severe headache. American Journal of Medicine. 1983;74(6A):36–42. (Guideline Ref ID PETERS1983) [PubMed: 6344625]
620.: Peters M, Abu-Saad HH, Vydelingum V, Dowson A, Murphy M. Patients’ decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia. 2003;23(8):833–841. (Guideline Ref ID PETERS2003) [PubMed: 14510931]
621.: Peters M, Abu-Saad HH, Vydelingum V, Dowson A, Murphy M. Migraine and chronic daily headache management: a qualitative study of patients’ perceptions. Scandinavian Journal of Caring Sciences. 2004;18(3):294–303. (Guideline Ref ID PETERS2004) [PubMed: 15355524]
622.: Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy M. The patients’ perceptions of migraine and chronic daily headache: a qualitative study. Journal of Headache and Pain. 2005;6(1):40–47. (Guideline Ref ID PETERS2005) [PMC free article: PMC3451956] [PubMed: 16362190]
623.: Pfaffenrath V, Cunin G, Sjonell G, Prendergast S. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache. 1998;38(3):184–190. (Guideline Ref ID PFAFFENRATH1998) [PubMed: 9563208]
624.: Pfaffenrath V, Diener HC. Amitriptyline versus amitriptyline-N-oxide versus placebo in the treatment of chronic tension type headache: A multi-centre, randomised parallel-group double-blind study. Cephalalgia. 1991;11(SUPPL 11):329–330. (Guideline Ref ID PFAFFENRATH1991)
625.: Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-Von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis - A double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia. 2002;22(7):523–532. (Guideline Ref ID PFAFFENRATH2002) [PubMed: 12230594]
626.: Pfaffenrath V, Diener HC, Isler H, Meyer C, Scholz E, Taneri Z, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia. 1994;14(2):149–155. (Guideline Ref ID PFAFFENRATH1994) [PubMed: 8062354]
627.: Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, et al. Magnesium in the prophylaxis of migraine - A double-blind, placebo-controlled study. Cephalalgia. 1996;16(6):436–440. (Guideline Ref ID PFAFFENRATH1996) [PubMed: 8902254]
628.: Phillip D, Lyngberg A, Jensen R. Assessment of headache diagnosis. A comparative population study of a clinical interview with a diagnostic headache diary. Cephalalgia. 2007;27(1):1–8. (Guideline Ref ID PHILLIP2007) [PubMed: 17212676]
629.: Pilgrim AJ. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol. 1991;31(5):295–299. (Guideline Ref ID PILGRIM1991) [PubMed: 1653136]
630.: Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001;21(9):878–883. (Guideline Ref ID PINI2001) [PubMed: 11903281]
631.: Pini LA, Del BE, Zanchin G, Sarchielli P, Di TG, Prudenzano MP, et al. Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium. Journal of Headache & Pain. 2008;9(6):367–373. (Guideline Ref ID PINI2008) [PMC free article: PMC3452084] [PubMed: 18815727]
632.: Pini LA, Fabbri L, Cavazzuti L. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group. Int J Clin Pharmacol Res. 1999;19(2):57–64. (Guideline Ref ID PINI1999) [PubMed: 10669900]
633.: Pini LA, Sternieri E, Fabbri L, Zerbini O, Bamfi F. High efficacy and low frequency of headache recurrence after oral sumatriptan. The Oral Sumatriptan Italian Study Group. J Int Med Res. 1995;23(2):96–105. (Guideline Ref ID PINI1995) [PubMed: 7601299]
634.: Pita E, Higueras A, Bolanos J, Perez N, Mundo A. Propranolol and migraine. A clinical trial. Archivos De Farmacologia y. Toxicologia. 1977;3(3):273–278. (Guideline Ref ID PITA1977) [PubMed: 350168]
635.: Porter D, Leviton A, Slack WV, Graham JR. A headache chronicle: the daily recording of headaches and their correlates. Journal of Chronic Diseases. 1981;34(9–10):481–486. (Guideline Ref ID PORTER1981) [PubMed: 7276138]
636.: Pradalier A, Rancurel G, Dordain G, Verdure L, Rascol A, Dry J. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia. 1985;5(2):107–113. (Guideline Ref ID PRADALIER1985) [PubMed: 3926322]
637.: Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, et al. Double-blind placebo controlled study of the use of long-acting propranolol in migraine prophylaxis. Cephalalgia. 1989;9(SUPPL 10):367–368. (Guideline Ref ID PRADALIER1989)
638.: Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson C, et al. Long-acting propranolol in migraine prophylaxis: Results of a double-blind, placebo-controlled study. Cephalalgia. 1989;9(4):247–253. (Guideline Ref ID PRADALIER1989A) [PubMed: 2692838]
639.: Presthus J. BC 105 and methysergide (Deseril) in migraine prophylaxis. Acta Neurologica Scandinavica. 1971;47(4):514–518. (Guideline Ref ID PRESTHUS1971) [PubMed: 4941732]
640.: Prior MJ, Codispoti JR, Fu M. A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache. Headache. 2010;50(5):819–833. (Guideline Ref ID PRIOR2010) [PubMed: 20236342]
641.: Prior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia. 2002;22(9):740–748. (Guideline Ref ID PRIOR2002) [PubMed: 12421160]
642.: Pryse-Phillips W, Aube M, Gawel M, Nelson R, Purdy A, Wilson K. A headache diagnosis project. Headache. 2002;42(8):728–737. (Guideline Ref ID PRYSEPHILLIPS2002) [PubMed: 12390635]
643.: Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RF. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Canadian Journal of Neurological Sciences. 1992;19(3):333–339. (Guideline Ref ID PRYSEPHILLIPS1992) [PubMed: 1393842]
644.: Qin L, Gu S. Treatment of 60 Migraine Sufferers with Penetration Needling of Points and Point Selection Based on Following the Corresponding Meridians. International Journal of Clinical Acupuncture. 2006;15(3):163–167. (Guideline Ref ID QIN2006)
645.: Raieli V, Compagno A, Pandolfi E, La Vecchia M, Puma D, La Franca G, et al. Headache: what do children and mothers expect from pediatricians? Headache. 2010;50(2):290–300. (Guideline Ref ID RAIELI2010) [PubMed: 20039963]
646.: Rains JC. Change mechanisms in EMG biofeedback training: cognitive changes underlying improvements in tension headache. Headache. 2008;48(5):735–736. (Guideline Ref ID RAINS2008A) [PubMed: 18471128]
647.: Rains JC, Penzien DB. Behavioral research and the double-blind placebo-controlled methodology: Challenges in applying the biomedical standard to behavioral headache research. Headache. 2005;45(5):479–486. (Guideline Ref ID RAINS2005) [PubMed: 15953264]
648.: Ramchandren S, Cross BJ, Liebeskind DS. Emergent headaches during pregnancy: Correlation between neurologic examination and neuroimaging. American Journal of Neuroradiology. 2007;28(6):1085–1087. (Guideline Ref ID RAMCHANDREN2007) [PMC free article: PMC8134146] [PubMed: 17569963]
649.: Ramirez-Lassepas M, Espinosa CE, Cicero JJ, Johnston KL, Cipolle RJ, Barber DL. Predictors of intracranial pathologic findings in patients who seek emergency care because of headache. Archives of Neurology. 1997;54(12):1506–1509. (Guideline Ref ID RAMIREZ1997) [PubMed: 9400360]
650.: Rampello L, Alvano A, Chiechio S, Malaguarnera M, Raffaele R, Vecchio I, et al. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology. 2004;50(4):322–328. (Guideline Ref ID RAMPELLO2004) [PubMed: 15539864]
651.: Rana HM, Doshi DA, Virpariya KM, Shah AN, Somani SS. A study of clinical profile of HIV positive patients with neurological manifestations. HIV and AIDS Review. 2011;10(3):76–79. (Guideline Ref ID RANA2011)
652.: Rangaswamy K, Kalpana D. Treatment of tension headache by progressive muscle relaxation. Indian Journal of Clinical Psychology. 1988;15(2):61–63. (Guideline Ref ID RANGASWAMY1988)
653.: Rao BS, Das DG, Taraknath VR, Sarma Y. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurology India. 2000;48(3):223–226. (Guideline Ref ID RAO2000) [PubMed: 11025624]
654.: Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology. 2007;69(9):821–826. (Guideline Ref ID RAPOPORT2007) [PubMed: 17724283]
655.: Rasmussen BK, Jensen R, Olesen J. Questionnaire versus clinical interview in the diagnosis of headache. Headache. 1991;31(5):290–295. (Guideline Ref ID RASMUSSEN1991) [PubMed: 1860786]
656.: Ravishankar K. Medication overuse headache in India. Cephalalgia. 2008;28(11):1223–1226. (Guideline Ref ID RAVISHANKAR2008) [PubMed: 18983591]
657.: Ray M, Sood M, Kumar P, Khandelwal N, Singhi P. Neuroimaging findings in children with recurrent headaches: Experience from a developing country. European Journal of Paediatric Neurology. 2009;13:S67–S68. (Guideline Ref ID RAY2009)
658.: Reches A. Comparison of the efficacy, safety and tolerability of oral eletriptan and cafergot(r) in the acute treatment of migraine. European Journal of Neurology (Abstracts of the 4th Congress of the European Federation of Neurological Sciences, September 7–11, Lisbon, Portugal 1999). 1999;6(Suppl 3):57. (Guideline Ref ID RECHES1999)
659.: Rederich G, Rapoport A, Cutler N, Hazelrigg R, Jamerson B. Oral sumatriptan for the long-term treatment of migraine: clinical findings. Neurology. 1995;45(8 Suppl 7):S15–S20. (Guideline Ref ID REDERICH1995) [PubMed: 7644080]
660.: Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. American Journal of Obstetrics and Gynecology. 2000;182(1 Pt 1):159–163. (Guideline Ref ID REIFFELDRIDGE2000) [PubMed: 10649172]
661.: Reyes G, Volcy M, Massaro M. Clinical characteristics and therapeutic response of in-hospital treatment of patients with primary headaches. Experience from a neurological hospital in Medellin, Colombia. Headache. 2011;51:20–21. (Guideline Ref ID REYES2011)
662.: Rho YI, Chung HJ, Suh ES, Lee KH, Eun BL, Nam SO, et al. The role of neuroimaging in children and adolescents with recurrent headaches--multicenter study. Headache. 2011;51(3):403–408. (Guideline Ref ID RHO2011A) [PubMed: 21352214]
663.: Richardson GM, McGrath PJ. Cognitive-behavioral therapy for migraine headaches: A minimal-therapist-contact approach versus a clinic-based approach. Headache. 1989;29(6):352–357. (Guideline Ref ID RICHARDSON1989) [PubMed: 2759842]
664.: Richardson GM, McGrath PJ, Cunningham SJ, Humphreys P. Validity of the headache diary for children. Headache. 1983;23(4):184–187. (Guideline Ref ID RICHARDSON1983) [PubMed: 6885410]
665.: Richman PB, Allegra J, Eskin B, Doran J, Reischel U, Kaiafas C, et al. A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache. American Journal of Emergency Medicine. 2002;20(1):39–42. (Guideline Ref ID RICHMAN2002) [PubMed: 11781912]
666.: Richter IL, McGrath PJ, Humphreys PJ, Goodman JT, Firestone P, Keene D. Cognitive and relaxation treatment of paediatric migraine. Pain. 1986;25(2):195–203. (Guideline Ref ID RICHTER1986) [PubMed: 3523394]
667.: Rizzato B, Leone G, Misaggi G, Zivi I, Diomedi M. Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study. Clinical Neuropharmacology. 2011;34(2):74–78. (Guideline Ref ID RIZZATO2011) [PubMed: 21412201]
668.: Rokicki LA, Holroyd KA, France CR, Lipchik GL, France JL, Kvaal SA. Change mechanisms associated with combined relaxation/EMG biofeedback training for chronic tension headache. Applied Psychophysiology & Biofeedback. 1997;22(1):21–41. (Guideline Ref ID ROKICKI1997) [PubMed: 9287253]
669.: Rosen JA. Observations on the efficacy of propranolol for the prophylaxis of migraine. Annals of Neurology. 1983;13(1):92–93. (Guideline Ref ID ROSEN1983) [PubMed: 6338806]
670.: Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26(9):1097–1105. (Guideline Ref ID ROSSI2006) [PubMed: 16919060]
671.: Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008;28(11):1196–1200. (Guideline Ref ID ROSSI2008) [PubMed: 18727648]
672.: Rossi P, Jensen R, Nappi G, Allena M. COMOESTAS Consortium. A narrative review on the management of medication overuse headache: the steep road from experience to evidence. Journal of Headache and Pain. 2009;10(6):407–417. (Guideline Ref ID ROSSI2009) [PMC free article: PMC3476213] [PubMed: 19802522]
673.: Rothman RE, Keyl PM, McArthur JC, Beauchamp NJ Jr, Danyluk T, Kelen GD. A decision guideline for emergency department utilization of noncontrast head computed tomography in HIV-infected patients. Academic Emergency Medicine. 1999;6(10):1010–1019. (Guideline Ref ID ROTHMAN1999) [PubMed: 10530659]
674.: Rozen TD. High oxygen flow rates for cluster headache. Neurology. 2004;63(3):593. (Guideline Ref ID ROZEN2004) [PubMed: 15304611]
675.: Rozen TD. Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective). Headache. 2006;46(5):750–753. (Guideline Ref ID ROZEN2006) [PubMed: 16643577]
676.: Rueda-Sanchez M, Diaz-Martinez LA. Validation of a migraine screening questionnaire in a Colombian university population. Cephalalgia. 2004;24(10):894–899. (Guideline Ref ID RUEDASANCHEZ2004) [PubMed: 15377322]
677.: Ruiz de Velasco I, Gonzalez N, Etxeberria Y, Garcia-Monco JC. Quality of life in migraine patients: a qualitative study. Cephalalgia. 2003;23(9):892–900. (Guideline Ref ID RUIZDEVELASCO2003) [PubMed: 14616931]
678.: Russell MB, Iversen HK, Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia. 1994;14(2):107–117. (Guideline Ref ID RUSSELL1994) [PubMed: 8062348]
679.: Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 1992;12(6):369–374. (Guideline Ref ID RUSSELL1992) [PubMed: 1473140]
680.: Ryan RE Sr, Ryan RE Jr, Sudilovsky A. Nadolol and placebo comparison study in the prophylactic treatment of migraine. Panminerva Medica. 1982;24(2):89–94. (Guideline Ref ID RYAN1982) [PubMed: 6128710]
681.: Salazar G, Fragoso M, Vergez L, Sergio P, Cuello D. Metoclopramide as an analgesic in severe migraine attacks: an open, single-blind, parallel control study. Recent Patents on Cns Drug Discovery. 2011;6(2):141–145. (Guideline Ref ID SALAZAR2011) [PubMed: 21585330]
682.: Samaan Z, MacGregor EA, Andrew D, McGuffin P, Farmer A. Diagnosing migraine in research and clinical settings: the validation of the Structured Migraine Interview (SMI). BMC Neurology. 2010;10:7. (Guideline Ref ID SAMAAN2010) [PMC free article: PMC2824671] [PubMed: 20074361]
683.: Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia. 2010;30(3):329–336. (Guideline Ref ID SANCES2010) [PubMed: 19614697]
684.: Sances G, Tassorelli C, Ghiotto N. The development of an electronic web-diary for the monitoring of primary headaches. In: Jensen R, Diener HC, Olesen J, editors. Headache clinics: organization, patients and treatment. Oxford: Oxford University Press; 2003. pp. 157–162. (Guideline Ref ID SANCES2003)
685.: Sandor PS, Di CL, Coppola G, Saenger U, Fumal A, Magis D, et al. Coenzyme Q-10 for migraine prophylaxis: The first RCT. Focus on Alternative and Complementary Therapies. 2005;10(3):194–195. (Guideline Ref ID SANDOR2005)
686.: Sandrini G, Franchini S, Lanfranchi S, Granella F, Manzoni GC, Nappi G. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. Int J Clin Pharmacol Res. 1998;18(3):145–150. (Guideline Ref ID SANDRINI1998) [PubMed: 9825271]
687.: Saper J, Dahlof C, So Y, Tfelt-Hansen P, Malbecq W, Loeys T, et al. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial. Headache. 2006;46(2):264–275. (Guideline Ref ID SAPER2006) [PubMed: 16492236]
688.: Saper J, Klapper J, Mathew N, Rapoport A, Phillips S, Bernstein J. Intranasal civamide for the treatment of episodic cluster headaches. Headache: The Journal of Head & Face Pain. 2003;43(3):306–307. (Guideline Ref ID SAPER2003)
689.: Saper JR, Klapper J, Mathew NT, Rapoport A, Phillips SB, Bernstein JE. Intranasal civamide for the treatment of episodic cluster headaches. Archives of Neurology. 2002;59(6):990–994. (Guideline Ref ID SAPER2002) [PubMed: 12056936]
690.: Saper JR, Silberstein SD, Lake AE III, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34(9):497–502. (Guideline Ref ID SAPER1994) [PubMed: 8002320]
691.: Sargent J, Kirchner JR, Davis R, Kirkhart B. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology. 1995;45(8 Suppl 7):S10–S14. (Guideline Ref ID SARGENT1995) [PubMed: 7644079]
692.: Sargent J, Solbach P, Coyne L, Spohn H, Segerson J. Results of a controlled, experimental, outcome study of nondrug treatments for the control of migraine headaches. Journal of Behavioral Medicine. 1986;9(3):291–323. (Guideline Ref ID SARGENT1986) [PubMed: 3746900]
693.: Sargent J, Solbach P, Damasio H. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache. 1985;25(6):320–324. (Guideline Ref ID SARGENT1985) [PubMed: 3902723]
694.: Sargent JD, Baumel B, Peters K, Diamond S, Saper JR, Eisner LS, et al. Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine. Headache. 1988;28(4):263–266. (Guideline Ref ID SARGENT1988A) [PubMed: 3139584]
695.: Sargent JD, Lawson RC, Solbach P, Coyne L. Use of CT scans in an out-patient headache population: An evaluation. Headache. 1979;19(7):388–390. (Guideline Ref ID SARGENT1979) [PubMed: 511543]
696.: Sargent JD, Peters K, Goldstein J, Madison DS, Solbach P. Naproxen sodium for muscle contraction headache treatment. Headache. 1988;28(3):180–182. (Guideline Ref ID SARGENT1988) [PubMed: 3290156]
697.: Sartory G, Muller B, Metsch J, Pothmann R. A comparison of psychological and pharmacological treatment of pediatric migraine. Behaviour Research & Therapy. 1998;36(12):1155–1170. (Guideline Ref ID SARTORY1998) [PubMed: 9745800]
698.: Savani N, Brautaset NJ, Reunanen M, Szirmai I, Ashford EA, Hassani H, et al. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. Int J Clin Pract Suppl. 1999;105:7–15. (Guideline Ref ID SAVANI1999) [PubMed: 10692717]
699.: Schachtel BP, Furey SA, Thoden WR. Nonprescription ibuprofen and acetaminophen in the treatment of tension-type headache. Journal of Clinical Pharmacology. 1996;36(12):1120–1125. (Guideline Ref ID SCHACHTEL1996) [PubMed: 9013368]
700.: Schachtel BP, Thoden WR. Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache. 1988;28(7):471–474. (Guideline Ref ID SCHACHTEL1988) [PubMed: 3072316]
701.: Scharff L, Marcus DA, Masek BJ. A controlled study of minimal-contact thermal biofeedback treatment in children with migraine. Journal of Pediatric Psychology. 2002;27(2):109–119. (Guideline Ref ID SCHARFF2002) [PubMed: 11821495]
702.: Scherl ER, Wilson JF. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache. 1995;35(5):256–259. (Guideline Ref ID SCHERL1995) [PubMed: 7775186]
703.: Schievink WI, Maya MM. Frequency of intracranial aneurysms in patients with spontaneous intracranial hypotension. Journal of Neurosurgery. 2011;115(1):113–115. (Guideline Ref ID SCHIEVINK2011) [PubMed: 21395391]
704.: Schnider P, Aull S, Baumgartner C, Marterer A, Wober C, Zeiler K, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia. 1996;16(7):481–461. (Guideline Ref ID SCHNIDER1996) [PubMed: 8933992]
705.: Schoenen J, De KN, Giurgea S, Herroelen L, Jacquy J, Louis P, et al. Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia. Cephalalgia. 2008;28(10):1095–1105. (Guideline Ref ID SCHOENEN2008) [PubMed: 18644036]
706.: Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50(2):466–470. (Guideline Ref ID SCHOENEN1998) [PubMed: 9484373]
707.: Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ (Clinical Research Ed). 2001;322(7277):19–22. (Guideline Ref ID SCHRADER2001) [PMC free article: PMC26600] [PubMed: 11141144]
708.: Schulman EA, Dermott KF. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache. 2003;43(7):729–733. (Guideline Ref ID SCHULMAN2003) [PubMed: 12890127]
709.: Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ. 2009;339(7728):1015. (Guideline Ref ID SCHURKS2009A) [PMC free article: PMC2768778] [PubMed: 19861375]
710.: Schwartz SM, Petitti DB, Siscovick DS, Longstreth WTJ, Sidney S, Raghunathan TE, et al. Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke; a Journal of Cerebral Circulation. 1998;29(11):2277–2284. (Guideline Ref ID SCHWARTZ1998) [PubMed: 9804634]
711.: Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, et al. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders. Cephalalgia. 2011;31(7):786–796. (Guideline Ref ID SEEBURGER2011) [PubMed: 21078681]
712.: Sempere AP, Porta-Etessam J, Medrano V, Garcia-Morales I, Concepcion L, Ramos A, et al. Neuroimaging in the evaluation of patients with non-acute headache. Cephalalgia. 2005;25(1):30–35. (Guideline Ref ID SEMPERE2005) [PubMed: 15606567]
713.: Seng EK, Holroyd KA. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Annals of Behavioral Medicine. 2010;40(3):235–247. (Guideline Ref ID SENG2010) [PubMed: 20812037]
714.: Sham JS, Choy D, Wei WI, Yau CC. Value of clinical follow-up for local nasopharyngeal carcinoma relapse. Head & Neck. 1992;14(3):208–217. (Guideline Ref ID SHAM1992) [PubMed: 1587738]
715.: Shanklin DR, Wolfson SL. Therapeutic oxygen as a possible cause of pulmonary hemorrhage in premature infants. New England Journal of Medicine. 1967;277(16):833–837. (Guideline Ref ID SHANKLIN1967) [PubMed: 4859948]
716.: Sharma S, Prasad A, Nehru R, Anand KS, Rishi RK, Chaturvedi S, et al. Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine. Headache. 2002;42(9):896–902. (Guideline Ref ID SHARMA2002) [PubMed: 12390617]
717.: Shaughnessy A. Does the addition of caffeine to ibuprofen improve its analgesic effectiveness in the treatment of a tension headache?... Evidence-Based Practice. 2001;4(1):3–4. commentary on Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. CLIN PHARMACOL THER. 2000;68:312–9. insert. (Guideline Ref ID SHAUGHNESSY2001)
718.: Shields KE, Wiholm B-E, Hostelley LS, Striano LF, Arena SR, Sharrar RG. Monitoring outcomes of pregnancy following drug exposure: A company-based pregnancy registry program. Drug Safety. 2004;27(6):353–367. (Guideline Ref ID SHIELDS2004) [PubMed: 15144230]
719.: Shin HE, Park JW, Kim YI, Lee KS. Headache Impact Test-6 (HIT-6) Scores for Migraine Patients: Their Relation to Disability as Measured from a Headache Diary. Journal of Clinical Neurology. 2008;4(4):158–163. (Guideline Ref ID SHIN2008) [PMC free article: PMC2686853] [PubMed: 19513291]
720.: Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Archives of Internal Medicine. 1996;156(15):1725–1728. (Guideline Ref ID SHRESTHA1996) [PubMed: 8694672]
721.: Shuhaiber S, Pastuszak A, Schick B, Matsui D, Spivey G, Brochu J, et al. Pregnancy outcome following first trimester exposure to sumatriptan. Neurology. 1998;51(2):581–583. (Guideline Ref ID SHUHAIBER1998) [PubMed: 9710039]
722.: Sicuteri F, Geppetti P, Marabini S, Lembeck F. Pain relief by somatostatin in attacks of cluster headache. Pain. 1984;18(4):359–365. (Guideline Ref ID SICUTERI1984) [PubMed: 6145138]
723.: Silberstein S, Saper J, Berenson F, Somogyi M, McCague K, D’Souza J. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. Neurology. 2008;70(7):548–555. (Guideline Ref ID SILBERSTEIN2008A) [PubMed: 18268247]
724.: Silberstein SD. Headaches and women: Treatment of the pregnant and lactating migraineur. Headache. 1993;33(10):533–540. (Guideline Ref ID SILBERSTEIN1993) [PubMed: 7904984]
725.: Silberstein SD. Efficacy of topiramate in migraine prophylaxis: a randomized controlled study Johns Hopkins. Advanced Studies in Medicine. 2002;2(21):758. (Guideline Ref ID SILBERSTEIN2002B)
726.: Silberstein SD, Hulihan J, Rezaul Karim M, Wu SC, Jordan D, Karvois D, et al. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: A randomized, placebo-controlled, double-blind, 12-week pilot study. Clinical Therapeutics. 2006;28(7):1002–1011. (Guideline Ref ID SILBERSTEIN2006A) [PubMed: 16990078]
727.: Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache. 2007;47(2):170–180. (Guideline Ref ID SILBERSTEIN2007A) [PubMed: 17300356]
728.: Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: Results of a large controlled trial. Archives of Neurology. 2004;61(4):490–495. (Guideline Ref ID SILBERSTEIN2004B) [PubMed: 15096395]
729.: Silberstein SD, Silberstein JR. Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE. Headache. 1992;32(9):439–445. (Guideline Ref ID SILBERSTEIN1992) [PubMed: 1446987]
730.: Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, et al. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache. 2009;49(8):1153–1162. (Guideline Ref ID SILBERSTEIN2009) [PubMed: 19719543]
731.: Silcocks P, Whitham D, Whitehouse WP. P3MC: a double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in children. Trials [Electronic Resource] 2010;11:71. (Guideline Ref ID SILCOCKS2010) [PMC free article: PMC2903577] [PubMed: 20553601]
732.: Silver BV, Blanchard EB, Williamson DA, Theobald DE, Brown DA. Temperature biofeedback and relaxation training in the treatment of migraine headaches. One-year follow-up. Biofeedback Self Regul. 1979;4(4):359–366. (Guideline Ref ID SILVER1979) [PubMed: 393306]
733.: Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia. 2004;23(8):820–824. (Guideline Ref ID SILVESTRINI2004) [PubMed: 14510929]
734.: Singer EJ, Kim J, Fahy-Chandon B, Datt A, Tourtellotte WW. Headache in ambulatory HIV-1-infected men enrolled in a longitudinal study. Neurology. 1996;47(2):487–494. (Guideline Ref ID SINGER1996) [PubMed: 8757026]
735.: Singer EJ, Zorilla C, Fahy-Chandon B, Chi S, Syndulko K, Tourtellotte WW. Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study. Pain. 1993;54(1):15–19. (Guideline Ref ID SINGER1993) [PubMed: 8378098]
736.: Singh A, Alter HJ, Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Academic Emergency Medicine. 2008;15(12):1223–1233. (Guideline Ref ID SINGH2008) [PubMed: 18976336]
737.: Singh NN, Misra S. Sertraline in chronic tension-type headache. Journal of the Association of Physicians of India. 2002;50:873–878. (Guideline Ref ID SINGH2002) [PubMed: 12126338]
738.: Siva A, Zarifoglu M, Ertas M, Saip S, Karli HN, Baykan B, et al. Validity of the ID-Migraine screener in the workplace. Neurology. 2008;70(16):1337–1345. (Guideline Ref ID SIVA2008) [PubMed: 18413587]
739.: Sjaastad O, Stensrud P. Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis. Acta Neurologica Scandinavica. 1972;48(1):124–128. (Guideline Ref ID SJAASTAD1972) [PubMed: 4401692]
740.: Skomo ML, Desselle SP, Shah N. Migraineurs’ perceptions of and interactions with pharmacists: A qualitative study. International Journal of Pharmacy Practice. 2008;16(6):357–363. (Guideline Ref ID SKOMO2008B)
741.: Slawson D. Which intranasal formulation is most effective in the treatment of acute migraine: sumatriptan or dihydroergotamine (DHE)? Evidence-Based Practice. 2000;3(10):8. 2 p. (Guideline Ref ID SLAWSON2000)
742.: Smith LA, Oldman AD, McQuay HJ, Moore RA. Eletriptan for acute migraine WITHDRAWN. Cochrane Database of Systematic Reviews. 2001;(3):CD003224. (Guideline Ref ID SMITH2001) [PMC free article: PMC6564092] [PubMed: 17636718]
743.: Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2005;45(8):983–991. (Guideline Ref ID SMITH2005) [PubMed: 16109111]
744.: Sobri M, Lamont AC, Alias NA, Win MN. Red flags in patients presenting with headache: Clinical indications for neuroimaging. British Journal of Radiology. 2003;76(908):532–535. (Guideline Ref ID SOBRI2003) [PubMed: 12893694]
745.: Söderberg E, Carlsson J, Stener-Victorin E. Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia. 2006;26(11):1320–1329. (Guideline Ref ID SODERBERG2006) [PubMed: 17059439]
746.: Soderberg E, Carlsson J, Stener-Victorin E, Dahlof C. Subjective well-being in patients with chronic tension-type headache: Effect of acupuncture, physical training, and relaxation training. Clinical Journal of Pain. 2011;27(5):448–456. (Guideline Ref ID SODERBERG2011) [PubMed: 21317776]
747.: Soges LJ, Cacayorin ED, Petro GR, Ramachandran TS. Migraine: evaluation by MR. American Journal of Neuroradiology. 1988;9(3):425–429. (Guideline Ref ID SOGES1988) [PMC free article: PMC8332802] [PubMed: 3132817]
748.: Solomon GD. Chronic tension-type headache: advice for the viselike-headache patient. Cleveland Clinic Journal of Medicine. 2002;69(2):167–172. (Guideline Ref ID SOLOMON2002) [PubMed: 11990648]
749.: Sorbi M. Differential effects of training in relaxation and stress-coping in patients with migraine. Headache. 1986;26(9):473–481. (Guideline Ref ID SORBI1986) [PubMed: 3536801]
750.: Sorbi M, Tellegen B, Du Long A. Long-term effects of training in relaxation and stress-coping in patients with migraine: a 3-year follow-up. Headache. 1989;29(2):111–121. (Guideline Ref ID SORBI1989) [PubMed: 2651355]
751.: Sorensen HT, Czeizel AE, Rockenbauer M, Steffensen FH, Olsen J. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstetricia Et Gynecologica Scandinavica. 2001;80(5):397–401. (Guideline Ref ID SORENSEN2001) [PubMed: 11328214]
752.: Sotaniemi KA, Rantala M, Pyhtinen J, Myllyla VV. Clinical and CT correlates in the diagnosis of intracranial tumours. Journal of Neurology, Neurosurgery and Psychiatry. 1991;54(7):645–647. (Guideline Ref ID SOTANIEMI1991) [PMC free article: PMC1014438] [PubMed: 1895130]
753.: Steardo L, Bonuso S, Di Stasio E, Marano E. Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide. Acta Neurologica. 1982;4(3):196–204. (Guideline Ref ID STEARDO1982) [PubMed: 7136885]
754.: Steger JC, Harper RG. Comprehensive biofeedback versus self-monitored relaxation in the treatment of tension headache. Headache. 1980;20(3):137–142. (Guideline Ref ID STEGER1980) [PubMed: 6993419]
755.: Steiner TJ, Ahmed F, Findley LJ, MacGregor EA, Wilkinson M. S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. Cephalalgia. 1998;18(5):283–286. (Guideline Ref ID STEINER1988A) [PubMed: 9673809]
756.: Steiner TJ, Cook GE, Joseph R, Clifford Rose F. Double-blind dose-ranging comparison of metoprolol with placebo in the prophylaxis of classical and common migraine. Cephalalgia. 1985;5 Suppl 3:558–559. (Guideline Ref ID STEINER1985)
757.: Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia. 1997;17(2):109–112. (Guideline Ref ID STEINER1997) [PubMed: 9137848]
758.: Steiner TJ, Hering R, Couturier EG, Davies PT, Whitmarsh TE. Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia. 1997;17(6):673–675. (Guideline Ref ID STEINER1997A) [PubMed: 9350389]
759.: Steiner TJ, Joseph R, Hedman C, Rose FC. Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up. Headache. 1988;28(1):15–23. (Guideline Ref ID STEINER1988) [PubMed: 3277926]
760.: Steiner TJ, Lange R. Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia. 1998;18(1):38–43. (Guideline Ref ID STEINER1998) [PubMed: 9601623]
761.: Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia. 2003;23(1):59–66. (Guideline Ref ID STEINER2003) [PubMed: 12534583]
762.: Stensland P, Malterud K. Unravelling empowering internal voices-a case study on the interactive use of illness diaries. Family Practice. 2001;18(4):425–429. (Guideline Ref ID STENSLAND2001) [PubMed: 11477051]
763.: Stevenson RJ, Dutta D, MacWalter RS. The management of acute headache in adults in an acute admissions unit. Scottish Medical Journal. 1998;43(6):173–176. (Guideline Ref ID STEVENSON1998) [PubMed: 9924754]
764.: Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88(1):41–52. (Guideline Ref ID STEWART2000) [PubMed: 11098098]
765.: Stewart WF, Lipton RB, Simon D, Liberman J, Von KM. Validity of an illness severity measure for headache in a population sample of migraine sufferers. Pain. 1999;79(2–3):291–301. (Guideline Ref ID STEWART1999) [PubMed: 10068175]
766.: Stiell IG, Dufour DG, Moher D, Yen M, Beilby WJ, Smith NA. Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial. Annals of Emergency Medicine. 1991;20(11):1201–1205. (Guideline Ref ID STIELL1991) [PubMed: 1952306]
767.: Streng A, Linde K, Hoppe A, Pfaffenrath V, Hammes M, Wagenpfeil S, et al. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache. 2006;46(10):1492–1502. (Guideline Ref ID STRENG2006) [PubMed: 17115982]
768.: Stronks DL, Tulen JH, Bussmann HB, Mulder LJ, Passchier J. Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study. Headache. 2003;43(8):845–852. (Guideline Ref ID STRONKS2003) [PubMed: 12940805]
769.: Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia. 1999;19(1):44–49. (Guideline Ref ID SUHR1999) [PubMed: 10099859]
770.: Swanson JW. Topiramate for migraine prevention. Current Neurology & Neuroscience Reports. 2005;5(2):77–78. (Guideline Ref ID SWANSON2005) [PubMed: 15743542]
771.: Tarlaci S. Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clinical Neuropharmacology. 2009;32(5):254–258. (Guideline Ref ID TARLACI2009) [PubMed: 19667978]
772.: Tassorelli C, Sances G, Allena M, Ghiotto N, Bendtsen L, Olesen J, et al. The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres. Cephalalgia. 2008;28(10):1023–1030. (Guideline Ref ID TASSORELLI2008) [PubMed: 18624804]
773.: Tavola T, Gala C, Conte G, Invernizzi G. Traditional Chinese acupuncture in tension-type headache: a controlled study. Pain. 1992;48(3):325–329. (Guideline Ref ID TAVOLA1992) [PubMed: 1594255]
774.: Taylor TR, Evangelou N, Porter H, Lenthall R. Primary care direct access MRI for the investigation of chronic headache. Clinical Radiology. 2012;67(1):24–27. (Guideline Ref ID TAYLOR2012) [PubMed: 22088325]
775.: Tek D, Mellon M. The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache. Annals of Emergency Medicine. 1987;16(3):308–313. (Guideline Ref ID TEK1987) [PubMed: 3544982]
776.: Tepper SJ, Dahlöf CG, Dowson A, Newman L, Mansbach H, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004;44(9):856–864. (Guideline Ref ID TEPPER2004) [PubMed: 15447694]
777.: Tepper SJ, Zatochill M, Szeto M, Sheftell F, Tepper DE, Bigal M. Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool. Headache. 2008;48(10):1419–1425. (Guideline Ref ID TEPPER2008) [PubMed: 19076645]
778.: Tepper SJ, Kori SH, Goadsby PJ, Winner PK, Wang MH, Silberstein SD, et al. MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments. Mayo Clinic Proceedings. 2011;86(10):948–955. (Guideline Ref ID TEPPER2011) [PMC free article: PMC3184024] [PubMed: 21964172]
779.: Tfelt-Hansen P. Acute pharmacotherapy of migraine, tension-type headache, and cluster headache. Journal of Headache and Pain. 2007;8(2):127–134. (Guideline Ref ID TFELTHANSEN2007) [PMC free article: PMC3476138] [PubMed: 17497267]
780.: Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet. 1995;346(8980):923–926. (Guideline Ref ID TFELTHANSEN1995) [PubMed: 7564725]
781.: Tfelt-Hansen P, Krabbe A. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia. 1981;1(1):29–32. (Guideline Ref ID TFELTHANSEN1981) [PubMed: 15645831]
782.: Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia. 1984;4(2):107–111. (Guideline Ref ID TFELTHANSEN1984) [PubMed: 6375873]
783.: Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurologica Scandinavica. 1984;69(1):1–8. (Guideline Ref ID TFELTHANSEN1984A) [PubMed: 6367336]
784.: Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W, et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache. 1998;38(10):748–755. (Guideline Ref ID TFELTHANSEN1998) [PubMed: 11284463]
785.: The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol. 1992;32(3):177–184. (Guideline Ref ID OSAMCSC1992) [PubMed: 1317294]
786.: The Oral Sumatriptan Dose-Defining Study Group. Sumatriptan--an oral dose-defining study. Eur Neurol. 1991;31(5):300–305. (Guideline Ref ID ANON1991A) [PubMed: 1653137]
787.: The Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol. 1991;31(5):306–313. (Guideline Ref ID ANON1991B) [PubMed: 1653138]
788.: Thomas R, Cook A, Main G, Taylor T, Galizia CE, Swingler R. Primary care access to computed tomography for chronic headache. British Journal of General Practice. 2010;60(575):426–430. (Guideline Ref ID THOMAS2010) [PMC free article: PMC2880741] [PubMed: 20529496]
789.: Thomas SH, Stone CK, Ray VG, Whitley TW. Intravenous versus rectal prochlorperazine in the treatment of benign vascular or tension headache: A randomized, prospective, double-blind trial. Annals of Emergency Medicine. 1994;24(5):923–927. (Guideline Ref ID THOMAS1994) [PubMed: 7978566]
790.: Thompson M, Gawel M, Desjardins B, Ferko N, Grima D. An economic evaluation of rizatriptan in the treatment of migraine. Pharmacoeconomics. 2005;23(8):837–850. (Guideline Ref ID THOMPSON2005) [PubMed: 16097844]
791.: Tietjen GE. The relationship of migraine and stroke. Neuroepidemiology. 2000;19(1):13–19. (Guideline Ref ID TIETJEN2000) [PubMed: 10654284]
792.: Tietjen GE, Athanas K, Utley C, Herial NA, Khuder SA. The combination of naratriptan and prochlorperazine in migraine treatment. Headache. 2005;45(6):751–753. (Guideline Ref ID TIETJEN2005) [PubMed: 15953309]
793.: Titus F, Escamilla C, Gomes Da Costa Palmeira MM, Leira R, Monteiro JMP. A double-blind comparison of lysine acetylsalicylate plus metoclopramide vs ergotamine plus caffeine in migraine: Effects on nausea, vomiting and headache symptoms. Clinical Drug Investigation. 2001;21(2):87–94. (Guideline Ref ID TITUS2001)
794.: Torelli P, Beghi E, Manzoni GC. Validation of a questionnaire for the detection of cluster headache. Headache. 2005;45(6):644–652. (Guideline Ref ID TORELLI2005) [PubMed: 15953296]
795.: Torelli P, Campana V, Cervellin G, Manzoni GC. Management of primary headaches in adult Emergency Departments: A literature review, the Parma ED experience and a therapy flow chart proposal. Neurological Sciences. 2010;31(5):545–553. (Guideline Ref ID TORELLI2010A) [PubMed: 20614150]
796.: Torelli P, Jensen R. Headache diaries and calendars. Handbook of Clinical Neurology. 2010;97:137–146. (Guideline Ref ID TORELLI2010) [PubMed: 20816416]
797.: Torelli P, Jensen R, Olesen J. Physiotherapy for tension-type headache: a controlled study. Cephalalgia. 2004;24(1):29–36. (Guideline Ref ID TORELLI2004) [PubMed: 14687010]
798.: Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bes A. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology. 1996;47(2):361–365. (Guideline Ref ID TOUCHON1996) [PubMed: 8757005]
799.: Trautmann E, Kroner-Herwig B. Internet-based self-help training for children and adolescents with recurrent headache: A pilot study. Behavioural and Cognitive Psychotherapy. 2008;36(2):241–245. (Guideline Ref ID TRAUTMANN2008)
800.: Trautmann E, Kroner-Herwig B. A randomized controlled trial of Internet-based self-help training for recurrent headache in childhood and adolescence. Behaviour Research & Therapy. 2010;48(1):28–37. (Guideline Ref ID TRAUTMANN2010) [PubMed: 19782343]
801.: Treves TA, Streiffler M, Korczyn AD. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks. Headache. 1992;32(6):280–282. (Guideline Ref ID TREVES1992) [PubMed: 1399547]
802.: Tribl GG, Schnider P, Wober C, Aull S, Auterith A, Zeiler K, et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia. 2001;21(6):691–696. (Guideline Ref ID TRIBL2001) [PubMed: 11531902]
803.: Trucco M, Meineri P, Ruiz L. Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. The Journal of Headache and Pain. 2005;6(4):334–337. (Guideline Ref ID TRUCCO2005) [PMC free article: PMC3452038] [PubMed: 16362704]
804.: Tso EL, Todd WC, Groleau GA, Hooper FJ. Cranial computed tomography in the emergency department evaluation of HIV-infected patients with neurologic complaints. Annals of Emergency Medicine. 1993;22(7):1169–1176. (Guideline Ref ID TSO1993) [PubMed: 8517569]
805.: Tsushima Y, Endo K. MR imaging in the evaluation of chronic or recurrent headache. Radiology. 2005;235(2):575–579. (Guideline Ref ID TSUSHIMA2005) [PubMed: 15858096]
806.: Tuchin PJ, Pollard H, Bonello R. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. Journal of Manipulative and Physiological Therapeutics. 2000;23(2):91–95. (Guideline Ref ID TUCHIN2000) [PubMed: 10714533]
807.: Tuchman MM, Hee A, Emeribe U, Silberstein S. Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs. 2008;22(10):877–886. (Guideline Ref ID TUCHMAN2008) [PubMed: 18788838]
808.: Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d’Anglejan-Chatillon J, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ. 1995;310(6983):830–833. (Guideline Ref ID TZOURIO1995) [PMC free article: PMC2549216] [PubMed: 7711619]
809.: Ueberall M. Sumatriptan in paediatric and adolescent migraine. Cephalalgia. 2001;21 Suppl 1:21–24. (Guideline Ref ID UEBERALL2001) [PubMed: 11678817]
810.: Usai S, Grazzi L, Andrasik F, D’Amico D, Rigamonti A, Bussone G. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up. Neurological Sciences. 2004;25 Suppl 3:S272–S273. (Guideline Ref ID USAI2004) [PubMed: 15549557]
811.: Usai S, Grazzi L, D’Amico D, Andrasik F, Bussone G. Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurological Sciences. 2008;29 Suppl 1:S176–S178. (Guideline Ref ID USAI2008) [PubMed: 18545928]
812.: Usai S, Grazzi L, D’Amico D, Andrasik F, Bussone G. Psychological variables in chronic migraine with medication overuse before and after inpatient withdrawal: results at 1-year follow-up. Neurological Sciences. 2009;30 Suppl 1:S125–S127. (Guideline Ref ID USAI2009) [PubMed: 19415442]
813.: Valenca MM, Valenca LP, Menezes TL. Computed tomography scan of the head in patients with migraine or tension-type headache. Arquivos De Neuro-Psiquiatria. 2002;60(3-A):542–547. (Guideline Ref ID VALENCA2002) [PubMed: 12244387]
814.: Valentinis L, Valent F, Mucchiut M, Barbone F, Bergonzi P, Zanchin G. Migraine in adolescents: validation of a screening questionnaire. Headache. 2009;49(2):202–211. (Guideline Ref ID VALENTINIS2009) [PubMed: 19222594]
815.: Van De Ven LLM, Franke CL, Koehler PJ. Prophylactic treatment of migraine with bisoprolol: A placebo- controlled study. Cephalalgia. 1997;17(5):596–599. (Guideline Ref ID VANDEVEN1997) [PubMed: 9251876]
816.: van den Brink M, Bandell-Hoekstra EN, Abu-Saad HH. The occurrence of recall bias in pediatric headache: a comparison of questionnaire and diary data. Headache. 2001;41(1):11–20. (Guideline Ref ID VANDENBRINK2001) [PubMed: 11168599]
817.: van Oosterhout WPJ, Weller CM, Stam AH, Bakels F, Stijnen T, Ferrari MD, et al. Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineurs. Cephalalgia. 2011;31(13):1359–1367. (Guideline Ref ID VANOOSTERHOUT2011) [PubMed: 21914734]
818.: van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology. 2003;60(4):630–633. (Guideline Ref ID VANVLIET2003) [PubMed: 12601104]
819.: Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls. Cephalalgia. 2011;31(14):1428–1438. (Guideline Ref ID VARKEY2011) [PMC free article: PMC3236524] [PubMed: 21890526]
820.: Vasconcellos E, Pina-Garza JE, Millan EJ, Warner JS. Analgesic rebound headache in children and adolescents. Journal of Child Neurology. 1998;13(9):443–447. (Guideline Ref ID VASCONCELLOS1998) [PubMed: 9733291]
821.: Vazquez-Barquero A, Ibanez FJ, Herrera S, Izquierdo JM, Berciano J, Pascual J. Isolated headache as the presenting clinical manifestation of intracranial tumors: a prospective study. Cephalalgia. 1994;14(4):270–272. (Guideline Ref ID VAZQUEZ1994) [PubMed: 7954755]
822.: Verhagen AP, Damen L, Berger MY, Passchier J, Merlijn V, Koes BW. Conservative treatments of children with episodic tension-type headache: A systematic review. Journal of Neurology. 2005;252(10):1147–1154. (Guideline Ref ID VERHAGEN2005) [PubMed: 16047110]
823.: Verhagen AP, Damen L, Berger MY, Passchier J, Merlijn V, Koes BW. Is any one analgesic superior for episodic tension-type headache? Journal of Family Practice. 2006;55(12):1064–1072. (Guideline Ref ID VERHAGEN2006) [PubMed: 17137543]
824.: Vernon H, Jansz G, Goldsmith CH, McDermaid C. A randomized, placebo-controlled clinical trial of chiropractic and medical prophylactic treatment of adults with tension-type headache: results from a stopped trial. Journal of Manipulative & Physiological Therapeutics. 2009;32(5):344–351. (Guideline Ref ID VERNON2009) [PubMed: 19539116]
825.: Vessey M, Painter R. Hospital referral for headache and oral contraceptive use: Findings in a large cohort study. British Journal of Family Planning. 1995;21(3):91–92. (Guideline Ref ID VESSEY1995)
826.: Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N. Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis. Health Technology Assessment. 2004;8(48):1–50. (Guideline Ref ID VICKERS2004) [PubMed: 15527670]
827.: Vincent CA. A controlled trial of the treatment of migraine by acupuncture. Clinical Journal of Pain. 1989;5(4):305–312. (Guideline Ref ID VINCENT1989) [PubMed: 2520420]
828.: Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group. Archives of Neurology. 1996;53(11):1132–1137. (Guideline Ref ID VISSER1996) [PubMed: 8912486]
829.: Viswanathan KN, Rajendiran C, Manohar DS, Balaraman VT. Cinnarizine-propranalol in migraine prophylaxis - A double blind clinical study. Cephalalgia. 1991;11(SUPPL 11):166–167. (Guideline Ref ID VISWANATHAN1991)
830.: von Graffenried B, Nuesch E. Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol. 1980;10 Suppl 2:225S–231S. (Guideline Ref ID VONGRAFFENRIED1980) [PMC free article: PMC1430191] [PubMed: 7002183]
831.: Vree ML, Schmidt J. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany. European Journal of Contraception and Reproductive Health Care. 2001;6(2):108–114. (Guideline Ref ID VREE2001) [PubMed: 11518448]
832.: Vukovi V, Kneevi-Pavli M, Tumpi-Jakovi J, Strineka M, Lovreni-Huzjan A, Demarin V. Headache management in a neurological emergency room. European Journal of Neurology. 2009;16(S3):96. (Guideline Ref ID VUKOVI2009)
833.: Walker J, Parisi S, Olive D. Analgesic rebound headache: experience in a community hospital. Southern Medical Journal. 1993;86(11):1202–1205. (Guideline Ref ID WALKER1993) [PubMed: 8235768]
834.: Walker Z, Walker RWH, Robertson MM, Stansfeld S. Antidepressant treatment of chronic tension-type headache: A comparison between fluoxetine and desipramine. Headache. 1998;38(7):523–528. (Guideline Ref ID WALKER1998) [PubMed: 15613168]
835.: Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43(6):601–610. (Guideline Ref ID WANG2003) [PubMed: 12786918]
836.: Wang HZ, Simonson TM, Greco WR, Yuh WT. Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms. Academic Radiology. 2001;8(5):405–408. (Guideline Ref ID WANG2001A) [PubMed: 11345271]
837.: Wang L, Zhang X, Guo J, Liu H, Zhang Y, Liu C, et al. Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial. Pain. 2011;152(8):1864–1871. (Guideline Ref ID WANG2011A) [PubMed: 21616596]
838.: Warner JS. The outcome of treating patients with suspected rebound headache. Headache. 2001;41(7):685–692. (Guideline Ref ID WARNER2001) [PubMed: 11554956]
839.: Waters WE. A randomized controlled trial of ergotamine tartrate. British Journal of Preventive & Social Medicine. 1970;24(1):65. (Guideline Ref ID WATERS1970B) [PMC free article: PMC1059255] [PubMed: 4908199]
840.: Wauquier A, McGrady A, Aloe L, Klausner T, Collins B. Changes in cerebral blood flow velocity associated with biofeedback-assisted relaxation treatment of migraine headaches are specific for the middle cerebral artery. Headache. 1995;35(6):358–362. (Guideline Ref ID WAUQUIER1995) [PubMed: 7635723]
841.: Weber RB, Reinmuth OM. The treatment of migraine with propranolol. Neurology. 1972;22(4):366–369. (Guideline Ref ID WEBER1972) [PubMed: 4552716]
842.: Weber-Schoendorfer C, Hannemann D, Meister R, Elefant E, Cuppers-Maarschalkerweerd B, Arnon J, et al. The safety of calcium channel blockers during pregnancy: A prospective, multicenter, observational study. Reproductive Toxicology. 2008;26(1):24–30. (Guideline Ref ID WEBER2008) [PubMed: 18585452]
843.: Weingarten S, Kleinman M, Elperin L, Larson EB. The effectiveness of cerebral imaging in the diagnosis of chronic headache. Archives of Internal Medicine. 1992;152(12):2457–2462. (Guideline Ref ID WEINGARTEN1992) [PubMed: 1456857]
844.: Wells NEJ. Comparison of the effectiveness of eletriptan, sumatriptan and CAFERGOT in reducing the time loss associated with migraine attacks. Journal of Drug Assessment. 2001;4(4):265–274. (Guideline Ref ID WELLS2001B)
845.: Wenzel RG, Sarvis CA, Krause ML. Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Pharmacotherapy. 2003;23(4):494–505. (Guideline Ref ID WENZEL2003) [PubMed: 12680479]
846.: Wessely P, Baumgartner C, Klingler D, Kreczi J, Meyerson N, Sailer L, et al. Preliminary results of a double-blind study with the new migraine prophylactic drug Gabapentin. Cephalalgia. 1987;7(Suppl 6):477–478. (Guideline Ref ID WESSELY1987)
847.: Whewell J. Methysergide in prophylaxis of migraine: a clinical trial in general practice. British Medical Journal. 1966;2(5510):394–395. (Guideline Ref ID WHEWELL1966) [PMC free article: PMC1943637] [PubMed: 5331176]
848.: White AR, Resch KL, Chan JC, Norris CD, Modi SK, Patel JN, et al. Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial. Cephalalgia. 2000;20(7):632–637. (Guideline Ref ID WHITE2000) [PubMed: 11128820]
849.: White D. Migrane update. ACE inhibitors and angiotensin II receptor blockers for migraine. Evidence-Based Practice. 2006;9(6):11–2. 2 p. (Guideline Ref ID WHITE2006)
850.: Wideroe TE, Vigander T. Propranolol in the treatment of migraine. British Medical Journal. 1974;2(5921):699–701. (Guideline Ref ID WIDEROE1974) [PMC free article: PMC1611139] [PubMed: 4604977]
851.: Wilkinson M. L-ASA compared to sumatriptan and parenteral placebo in the acute treatment of migraine. Cephalalgia. 1999;19(6):542. (Guideline Ref ID WILKINSON1999) [PubMed: 10448545]
852.: Williamson DA. Relaxation for the treatment of headache: Controlled evaluation of two group programs. Behavior Modification. 1984;8(3):407–424. (Guideline Ref ID WILLIAMSON1984) [PubMed: 6383339]
853.: Wilson JR, Foresman BH, Gamber RG, Wright T. Hyperbaric oxygen in the treatment of migraine with aura. Headache. 1998;38(2):112–115. (Guideline Ref ID WILSON1998) [PubMed: 9529766]
854.: Winkler R, Underwood P, Fatovich B, James R, Gray D. A clinical trial of a self-care approach to the management of chronic headache in general practice. Social Science & Medicine. 1989;29(2):213–219. (Guideline Ref ID WINKLER1989) [PubMed: 2665109]
855.: Winner P, Dalessio D, Mathew N, Sadowsky C, Turkewitz LJ, Sheftell F, et al. Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine. American Journal of Emergency Medicine. 1994;12(2):138–141. (Guideline Ref ID WINNER1994) [PubMed: 8161382]
856.: Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45(10):1304–1312. (Guideline Ref ID WINNER2005) [PubMed: 16324162]
857.: Winner P, Ricalde O, Le FB, Saper J, Margul B. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Archives of Neurology. 1996;53(2):180–184. (Guideline Ref ID WINNER1996) [PubMed: 8639069]
858.: Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, et al. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache. 2006;46(10):1503–1510. (Guideline Ref ID WINNER2006) [PubMed: 17115983]
859.: Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture treatment in patients with headache. Cephalalgia. 2008;28(4):334–345. (Guideline Ref ID WITT2008) [PubMed: 18315686]
860.: Wober-Bingol C, Wober C, Prayer D, Wagner-Ennsgraber C, Karwautz A, Vesely C, et al. Magnetic resonance imaging for recurrent headache in childhood and adolescence. Headache. 1996;36(2):83–90. (Guideline Ref ID WOBERBINGOL1996) [PubMed: 8742679]
861.: Wojcicki J, Samochowiec L, Lawczynski L, Szwed G, Olszewska M. A double-blind comparative evaluation of aspirin, paracetamol and paracetamol + caffeine (finimal) for their analgesic effectiveness. Archivum Immunologiae Et Therapiae Experimentalis. 1977;25(2):175. (Guideline Ref ID WOJCICKI1977) [PubMed: 326219]
862.: Worz R, Scherhag R. Treatment of chronic tension headache with doxepin or amitriptylinle Results of a double blind study. Headache Quarterly. 1990;1(3):216–223. (Guideline Ref ID WORZ1990)
863.: Yoon MS, Obermann M, Fritsche G, Slomke M, Dommes P, Schilf C, et al. Population-based validation of a German-language self-administered headache questionnaire. Cephalalgia. 2008;28(6):605–608. (Guideline Ref ID YOON2008) [PubMed: 18422724]
864.: You JJ, Gladstone J, Symons S, Rotstein D, Laupacis A, Bell CM. Patterns of care and outcomes after computed tomography scans for headache. Am J Med. 2011;124(1):58–63. (Guideline Ref ID YOU2011) [PubMed: 20961529]
865.: Yu J, Smith KJ, Brixner DI. Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application. CNS Drugs. 2010;24(8):695–712. (Guideline Ref ID YU2010) [PubMed: 20658800]
866.: Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. Journal of Headache & Pain. 2008;9(1):37–41. (Guideline Ref ID YUREKLI2008) [PMC free article: PMC3476175] [PubMed: 18231713]
867.: Zarifoglu M, Karli N, Taskapilioglu O. Can ID Migraine be used as a screening test for adolescent migraine? Cephalalgia. 2008;28(1):65–71. (Guideline Ref ID ZARIFOGLU2008) [PubMed: 17986273]
868.: Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Annals of Pharmacotherapy. 1999;33(1):61–72. (Guideline Ref ID ZED1999) [PubMed: 9972386]
869.: Zeeberg I, Orholm M, Nielsen JD. Femoxetine in the prophylaxis of migraine: A randomized comparison with placebo. Acta Neurologica Scandinavica. 1981;64(6):452–459. (Guideline Ref ID ZEEBERG1981) [PubMed: 6753446]
870.: Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006;26(10):1192–1198. (Guideline Ref ID ZEEBERG2006) [PubMed: 16961785]
871.: Zencirci B. Comparison of the effects of dietary factors in the management and prophylaxis of migraine. Journal of Pain Research. 2010;3:125–130. (Guideline Ref ID ZENCIRCI2010) [PMC free article: PMC3004646] [PubMed: 21197315]
872.: Zhang L, Hay JW. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine. CNS Drugs. 2005;19(7):635–642. (Guideline Ref ID ZHANG2005) [PubMed: 15984898]
873.: Zhang Y, Wang L, Liu H, Li N, Li J, Yi J. The design and protocol of acupuncture for migraine prophylaxis: A multicenter randomized controlled trial. Trials. 2009;10(25) (Guideline Ref ID ZHANG2009) [PMC free article: PMC2680846] [PubMed: 19389262]
874.: Zhao C, Stillman MJ. New developments in the pharmacotherapy of tension-type headaches. Expert Opinion on Pharmacotherapy. 2003;4(12):2229–2237. [Review] [79 refs] (Guideline Ref ID ZHAO2003) [PubMed: 14640922]
875.: Zhou H-Y, Zhou D. Influence of venlafaxine hydrochloride on the quality of life in patients with chronic tension headache. Chinese Journal of Clinical Rehabilitation. 2006;10(10):26–28. (Guideline Ref ID ZHOU2006)
876.: Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, et al. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia. 2007;27(4):315–324. (Guideline Ref ID ZISSIS2007) [PubMed: 17346304]

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

Bookshelf ID: NBK327500

Contents

< PrevNext >

PubReader
Print View
Cite this Page
National Clinical Guideline Centre (UK). Headaches: Diagnosis and Management of Headaches in Young People and Adults [Internet]. London: Royal College of Physicians (UK); 2012 Sep. (NICE Clinical Guidelines, No. 150.) Appendix P, References.
PDF version of this title (7.4M)